<SEC-DOCUMENT>0001140361-25-038548.txt : 20251020
<SEC-HEADER>0001140361-25-038548.hdr.sgml : 20251020
<ACCEPTANCE-DATETIME>20251017212813
ACCESSION NUMBER:		0001140361-25-038548
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20251020
DATE AS OF CHANGE:		20251017

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		251402204

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20057328_424b2.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<html style="font-family: Arial; font-size: 9pt; text-align: left;">
  <head>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff">
  <div style="font-size: 9pt;">
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfbfb6908055f4811a5d68ae91323442f">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify;"><img height="47" width="57" src="image0.jpg"></div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: right; font-size: 8pt; font-weight: bold;">Filed Pursuant to Rule 424(b)(2)</div>
              <div style="text-align: right; font-size: 8pt; font-weight: bold;">Registration Statement No. 333-283969</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf0536138764a4abcbc654a8c7d2aa94c">

          <tr>
            <td style="background-color: #000000; vertical-align: top; width: 100%;"><br>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; font-family: Arial; font-size: 8.5pt;">Pricing Supplement dated October 16, 2025 to the</div>
      <div style="text-align: justify; font-family: Arial; font-size: 8.5pt;">Product Supplement MLN-EI-1 dated February 26, 2025,</div>
      <div style="text-align: justify; font-family: Arial; font-size: 8.5pt;">Product Supplement MLN-ES-ETF-1 dated February 26, 2025,</div>
      <div style="text-align: justify; font-family: Arial; font-size: 8.5pt;">Underlier Supplement dated February 26, 2025 and</div>
      <div style="text-align: justify; font-family: Arial; font-size: 8.5pt;">Prospectus dated February 26, 2025</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zd32694208339478c9ac7b06ca826c480">

          <tr>
            <td style="width: 100%; vertical-align: top; border-width: 4px; border-style: solid; border-color: rgb(0, 176, 80);">
              <div style="text-align: center; color: rgb(0, 176, 80); font-size: 16pt;">The Toronto-Dominion Bank</div>
              <div style="text-align: center; font-size: 10pt;">$508,000</div>
              <div style="text-align: center; font-size: 10pt;">Autocallable Contingent Interest Barrier Notes Linked to the Least Performing of the shares of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
              <div style="text-align: center; font-size: 10pt;">Regional Banking ETF, the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index<font style="font-size: 8pt;">&#160;</font>Due October 19, 2028</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-size: 7.5pt;">The Toronto-Dominion Bank (&#8220;TD&#8221; or &#8220;we&#8221;) has offered the Autocallable Contingent Interest Barrier Notes (the &#8220;Notes&#8221;) linked to the least performing of the
        shares of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF, the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index<font style="font-size: 8pt;">&#160;</font>(each, a &#8220;Reference Asset&#8221; and together, the &#8220;Reference Assets&#8221;).
        We also refer to an exchange-traded fund as an &#8220;ETF&#8221;, a Reference Asset that is a share of an ETF as an &#8220;Equity Reference Asset&#8221; and a Reference Asset that is an index as an &#8220;Index Reference Asset&#8221;.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-family: Arial; font-size: 7.5pt;">The Notes will pay a Contingent Interest Payment on a Contingent Interest Payment Date (including the Maturity Date) at a per annum rate of
        approximately 10.60%<font style="font-size: 8pt;">&#160;</font>(the &#8220;Contingent Interest Rate&#8221;<font style="font-size: 8pt;">)</font> only if, on the related Contingent Interest Observation Date, the Closing Value of each Reference Asset is greater than
        or equal to its Contingent Interest Barrier Value, which is equal to 75.00% of its Initial Value. If, however, the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on a Contingent Interest Observation Date, no
        Contingent Interest Payment will accrue or be payable on the related Contingent Interest Payment Date. The Notes will be automatically called if, on any Call Observation Date, the Closing Value of each Reference Asset is greater than or equal to
        its Call Threshold Value, which is equal to 100.00% of its Initial Value. If the Notes are automatically called, on the first following Contingent Interest Payment Date (the &#8220;Call Payment Date&#8221;), we will pay a cash payment per Note equal to the
        Principal Amount, plus any Contingent Interest Payment otherwise due. No further amounts will be owed under the Notes. If the Notes are not automatically called, the amount we pay at maturity, in addition to any Contingent Interest Payment
        otherwise due, if anything, will depend on the Closing Value of each Reference Asset on its Final Valuation Date (each, its &#8220;Final Value&#8221;) relative to its Barrier Value, which is equal to 70.00% of its Initial Value, calculated as follows:</div>
      <table cellspacing="0" cellpadding="0" border="0" style="margin: 0px 0px 1pt; width: 100%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" class="DSPFListTable" id="z6609ae1e25f44f7385f1a55618e3580b">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 7.5pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 7.5pt;">If the Final Value of each Reference Asset is greater than or equal to its Barrier Value<font style="font-size: 8pt;">:</font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 3pt; font-family: Arial; font-size: 7.5pt;">the Principal Amount of $1,000</div>
      <table cellspacing="0" cellpadding="0" border="0" style="margin: 0px 0px 1pt; width: 100%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" class="DSPFListTable" id="z9a88f1deb8f24ef388b5dec04ef3aba0">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 7.5pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 7.5pt;">If the Final Value of any Reference Asset is less than its Barrier Value<font style="font-size: 8pt;">:</font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 3pt; font-family: Arial; font-size: 7.5pt;">the sum of (1) $1,000 plus (2) the product of (i) $1,000 times (ii) the Least Performing Percentage Change</div>
      <div style="text-align: justify; margin-bottom: 3pt; font-family: Arial; font-size: 7.5pt;"><font style="font-weight: bold; font-style: italic;">If the Notes are not automatically called and the Final Value of any Reference Asset is less than its
          Barrier Value, investors will suffer a percentage loss on their initial investment that is equal to the percentage decline of the Reference Asset with the lowest Percentage Change from its Initial Value to its Final Value (the &#8220;Least Performing
          Reference Asset&#8221;). Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">Any payments on the Notes are subject to our credit risk.</font></div>
      <div>
        <div style="text-align: justify; margin-bottom: 3pt; font-family: Arial; font-size: 8pt; font-weight: bold;">
          <table cellspacing="0" cellpadding="0" border="0" id="zc0350049c4384da4ad480b0786b27b11" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 1%; border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 98%; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);">
                  <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt; font-weight: bold;">The Notes do not guarantee the payment of any Contingent Interest Payments or the return of the Principal Amount. Investors are exposed to the market
                    risk of each Reference Asset on each Contingent Interest Observation Date (including the Final Valuation Date) and any decline in the value of one Reference Asset will not be offset or mitigated by a lesser decline or potential increase
                    in the value of any other Reference Asset. If the Final Value of any Reference Asset is less than its Barrier Value, investors may lose up to their entire investment in the Notes. Any payments on the Notes are subject to our credit
                    risk.</div>
                </td>
                <td style="width: 1%; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"><br>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-bottom: 2pt; font-family: Arial; font-size: 7.5pt;">The Notes are unsecured and are not savings accounts or insured deposits of a bank. The Notes are not insured or guaranteed by the Canada Deposit Insurance
        Corporation, the U.S. Federal Deposit Insurance Corporation or any other governmental agency or instrumentality of Canada or the United States. The Notes will not be listed or displayed on any securities exchange or electronic communications
        network.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-family: Arial; font-size: 7.5pt; font-weight: bold;">The Notes have complex features and investing in the Notes involves a number of risks. See &#8220;Additional Risk Factors&#8221; beginning on page P-7
        of this pricing supplement, &#8220;Additional Risk Factors Specific to the Notes&#8221; beginning on page PS-7 of the product supplement MLN-EI-1 and the product supplement MLN-ES-ETF-1, each dated February 26, 2025 (together, the &#8220;product supplements&#8221;) and
        &#8220;Risk Factors&#8221; on page 1 of the prospectus dated February 26, 2025 (the &#8220;prospectus&#8221;).</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-family: Arial; font-size: 7.5pt; font-weight: bold;">Neither the Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these Notes
        or determined that this pricing supplement, the product supplements, the underlier supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-family: Arial; font-size: 7.5pt;">We will deliver the Notes in book-entry only form through the facilities of The Depository Trust Company on the Issue Date against payment in immediately
        available funds.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-family: Arial; font-size: 7.5pt;">The estimated value of your Notes at the time the terms of your Notes were set on the Pricing Date was $908.60 per Note, as discussed further under
        &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; beginning on page P-10 and &#8220;Additional Information Regarding the Estimated Value of the Notes&#8221; on page P-26 of this pricing supplement. The estimated value is less than the
        public offering price of the Notes.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z24ee0b5ba1414c448fa9c7f3dba2871f">

          <tr>
            <td style="width: 17.87%; vertical-align: top; border-bottom: #D9D9D9 1px solid;"><br>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt; font-weight: bold;">Public Offering Price<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt; font-weight: bold;">Underwriting Discount<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1 2</sup></div>
            </td>
            <td style="width: 30.2%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt; font-weight: bold;">Proceeds to TD<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 17.87%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt;">Per Note</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$1,000.00</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$25.00</div>
            </td>
            <td style="width: 30.2%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$975.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 17.87%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt;">Total</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$508,000.00</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$12,700.00</div>
            </td>
            <td style="width: 30.2%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$495,300.00</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z750575cfa88a4e36b954f3c98ed09868" style="font-family: Arial; font-size: 9pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;">Certain dealers who purchase the Notes for sale to certain fee-based advisory accounts may have agreed to forgo some or all of their selling concessions, fees or
                  commissions. The public offering price for investors purchasing the Notes in these accounts may have been as low as $975.00 (97.50%) per Note.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zbee090d391fa4ad8a097a7fc0f529fae" style="font-family: Arial; font-size: 9pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;">TD Securities (USA) LLC (&#8220;TDS&#8221;) will receive a commission of $25.00 (2.50%) per Note and will use all of that commission to allow selling concessions to other dealers in
                  connection with the distribution of the Notes. Such other dealers may resell the Notes to other securities dealers at the Principal Amount less a concession not in excess of $25.00 per Note. TD will also periodically pay one or more
                  unaffiliated dealers a structuring fee and/or marketing fee of $5.00 per Note with respect to all of the Notes. TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS
                  a fee in connection with its role in the offer and sale of the Notes. See &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; herein.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; font-family: Arial; font-size: 7pt;">The public offering price, underwriting discount and proceeds to TD listed above relate to the Notes we issue initially. We may decide to sell additional Notes after the date of
        this pricing supplement, at public offering prices and with underwriting discounts and proceeds to TD that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the Notes will depend in part on the
        public offering price you pay for such Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">1</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z973aa4f43f8d4c7abbae8fcd579ac19f">

          <tr>
            <td style="width: 50%; vertical-align: middle;"><br>
            </td>
            <td style="width: 50%; vertical-align: middle;">
              <div style="text-align: right; font-size: 8pt; font-weight: bold;">Autocallable Contingent Interest Barrier Notes Linked to the Least Performing</div>
              <div style="text-align: right; font-size: 8pt; font-weight: bold;">of the shares of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF, the Nasdaq-100</div>
              <div style="text-align: right; font-size: 8pt; font-weight: bold;">Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
              <div style="text-align: right; margin-bottom: 6pt; font-size: 8pt; font-weight: bold;">Due October 19, 2028</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7b34e79c66ac45d2a5e66deb967ed32a">

          <tr>
            <td style="background-color: #000000; vertical-align: top; width: 100%;"><br>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Summary</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The information in this &#8220;Summary&#8221; section is qualified by the more detailed information set forth in this pricing supplement, the product supplements, the underlier supplement
        and the prospectus.</div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z34412c9fb4f84d89aa90784682e841a1">

          <tr>
            <td style="width: 23%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issuer:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Senior Debt Securities, Series H</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Type of Note:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Autocallable Contingent Interest Barrier Notes</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Term:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Approximately 3 years, subject to an automatic call</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Reference Assets:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">The shares of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF (Bloomberg ticker: KRE UP, &#8220;KRE&#8221;), the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (Bloomberg ticker: NDX, &#8220;NDX&#8221;) and the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
                Index (Bloomberg ticker: RTY, &#8220;RTY&#8221;)<font style="font-size: 8pt;">.</font> We also refer to KRE as an &#8220;Equity Reference Asset&#8221; and NDX and RTY as an &#8220;Index Reference Asset&#8221;.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">CUSIP / ISIN:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">89115HXM4 / US89115HXM41</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Agent:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">TDS</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Currency:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">U.S. Dollars</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Minimum Investment:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">$1,000 and minimum denominations of $1,000 in excess thereof</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Principal Amount:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">$1,000 per Note</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Pricing Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">October 16, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">October 21, 2025, which is the third DTC settlement day following the Pricing Date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), trades in the
                secondary market generally are required to settle in one DTC settlement day (&#8220;T+1&#8221;), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes in the secondary market on any date prior to
                one DTC settlement day before delivery of the Notes will be required, by virtue of the fact that each Note initially will settle in three DTC settlement days (&#8220;T+3&#8221;), to specify alternative settlement arrangements to prevent a failed
                settlement of the secondary market trade.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Final Valuation Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">The final Contingent Interest Observation Date, as specified below under &#8220;Contingent Interest Observation Dates&#8221;.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Maturity Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">October 19, 2028, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplements.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Call Feature:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">If the Closing Value of each Reference Asset on any Call Observation Date is greater than or equal to its Call Threshold Value, we will automatically call the Notes and, on the related
                Call Payment Date, we will pay you a cash payment per Note equal to the Principal Amount, plus any Contingent Interest Payment otherwise due. No further amounts will be owed to you under the Notes.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">2</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zca9616de97754e0c8a7fd82989e193e4">

          <tr>
            <td style="width: 23%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Call Threshold Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">With respect to KRE: $58.14<font style="font-size: 8pt;">&#160;</font>(100.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to NDX: 24,657.24<font style="font-size: 8pt;">&#160;</font>(100.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to RTY: 2,467.015<font style="font-size: 8pt;">&#160;</font>(100.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Call Threshold Value for each Reference Asset is determined by the Calculation Agent and, with respect to an Equity Reference Asset, is subject to adjustment as described under
                &#8220;General Terms of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the product supplement MLN-ES-ETF-1.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Call Observation Dates:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Monthly, on the 16th calendar day of each month, commencing on April 16, 2026 and ending on September 16, 2028, subject to postponement upon the occurrence of a market disruption event as
                described in the accompanying product supplements.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Call Payment Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">If the Notes are subject to an automatic call, the Call Payment Date will be the Contingent Interest Payment Date immediately following the relevant Call Observation Date, subject to
                postponement upon the occurrence of a market disruption event as described in the accompanying product supplements.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Contingent Interest Payment:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">If the Closing Value of each Reference Asset is greater than or equal to its Contingent Interest Barrier Value on any Contingent Interest Observation Date, a Contingent Interest Payment
                will be paid to you on the corresponding Contingent Interest Payment Date, in an amount equal to:</div>
              <div style="text-align: center; margin-bottom: 6pt;">Principal Amount &#215; Contingent Interest Rate &#215; <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>/<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">12</sub></div>
              <div style="text-align: justify; margin-bottom: 6pt;">If the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on any Contingent Interest Observation Date, you will receive no Contingent Interest Payment
                on the corresponding Contingent Interest Payment Date.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">All amounts used in or resulting from any calculation relating to a Contingent Interest Payment will be rounded upward or downward, as appropriate, to the nearest tenth of a cent.</div>
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Contingent Interest Payments on the Notes are not guaranteed. You will not receive a Contingent Interest Payment on a Contingent Interest Payment Date if the Closing
                Value of any Reference Asset on the related Contingent Interest Observation Date is less than its Contingent Interest Barrier Value.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Contingent Interest Rate:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">Approximately 10.60% per annum</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Contingent Interest Barrier</div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">With respect to KRE: $43.605<font style="font-size: 8pt;">&#160;</font>(75.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to NDX: 18,492.93<font style="font-size: 8pt;">&#160;</font>(75.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to RTY: 1,850.2613<font style="font-size: 8pt;">&#160;</font>(75.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Contingent Interest Barrier Value for each Reference Asset is determined by the Calculation Agent and, with respect to an Equity Reference Asset, is subject to adjustment as described
                under &#8220;General Terms of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the product supplement MLN-ES-ETF-1.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Contingent Interest</div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Observation Dates:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Monthly, on the 16th calendar day of each month, commencing on November 16, 2025 and ending on October 16, 2028<font style="font-size: 8pt;">&#160;</font>(the &#8220;Final Valuation Date&#8221;), subject
                to postponement upon the occurrence of a market disruption event as described in the accompanying product supplements.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; font-weight: bold;">Contingent Interest Payment</div>
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Dates:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">With respect to each Contingent Interest Observation Date, the third Business Day following the relevant Contingent Interest Observation Date, with the exception of the final Contingent
                Interest Payment Date, which will be the Maturity Date, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplements.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">3</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8edad6e654ba44b280ecf83e1d043866">

          <tr>
            <td style="width: 23%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Payment at Maturity:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">If the Notes are not automatically called, on the Maturity Date, in addition to any Contingent Interest Payment otherwise due, we will pay a cash payment, if anything,<font style="font-size: 8pt;">&#160;</font>per Note equal to:</div>
              <div style="text-align: justify; margin-bottom: 6pt;">If the Final Value of each Reference Asset is greater than or equal to its Barrier Value<font style="font-size: 8pt;">:</font></div>
              <div style="text-align: center; margin-bottom: 6pt;">Principal Amount of $1,000.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">If the Final Value of any Reference Asset is less than its Barrier Value<font style="font-size: 8pt;">:</font></div>
              <div style="text-align: center; margin-bottom: 3pt;">$1,000 + ($1,000 &#215; Least Performing Percentage Change).</div>
              <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-weight: bold; font-style: italic;">If the Notes are not automatically called and the Final Value of any Reference Asset is less than its Barrier Value, investors will
                  suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change. Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least
                  Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">Any payments on the Notes are subject to
                  our credit risk.</font></div>
              <div>All amounts used in or resulting from any calculation relating to the Payment at Maturity will be rounded upward or downward, as appropriate, to the nearest cent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Percentage Change:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">For each Reference Asset, the Percentage Change is the quotient, expressed as a percentage, of the following formula:</div>
              <div style="text-align: center;"><u>Final Value &#8211; Initial Value</u></div>
              <div style="text-align: center; margin-bottom: 6pt;">Initial Value</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Initial Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to KRE: $58.14</div>
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to NDX: 24,657.24</div>
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to RTY: 2,467.015</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Initial Value of each Reference Asset equals its Closing Value on the Pricing Date, as determined by the Calculation Agent and, with respect to an Equity Reference Asset,<font style="font-size: 8pt;">&#160;</font>subject to adjustment as described under &#8220;General Terms of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the product supplement MLN-ES-ETF-1.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Closing Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">With respect to an Index Reference Asset (or any &#8220;successor index&#8221; thereto, as defined in the product supplement MLN-EI-1) on any Trading Day, the Closing Value will be its closing value
                published by its sponsor (its &#8220;Index Sponsor&#8221;) as displayed on the relevant Bloomberg Professional<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> service (&#8220;Bloomberg&#8221;) page or any successor page or service.</div>
              <div style="text-align: justify; margin-bottom: 3pt;">With respect to an Equity Reference Asset, the Closing Value will be the closing sale price or last reported sale price (or, in the case of Nasdaq, the official closing price) for that
                Equity Reference Asset on a per-share or other unit basis, on any Trading Day for that Equity Reference Asset or, if such Equity Reference Asset is not quoted on any national securities exchange on that day, on any other market system or
                quotation system that is the primary market for the trading of such Equity Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Final Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">For each Reference Asset, the Closing Value of such Reference Asset on its Final Valuation Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Barrier Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">With respect to KRE: $40.698<font style="font-size: 8pt;">&#160;</font>(70.00% of its Initial Value).</div>
              <div style="margin-bottom: 6pt;">With respect to NDX: 17,260.068<font style="font-size: 8pt;">&#160;</font>(70.00% of its Initial Value).</div>
              <div style="margin-bottom: 6pt;">With respect to RTY: 1,726.9105<font style="font-size: 8pt;">&#160;</font>(70.00% of its Initial Value).</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Barrier Value for each Reference Asset is determined by the Calculation Agent and, with respect to an Equity Reference Asset, is subject to adjustment as described under &#8220;General Terms
                of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the product supplement MLN-ES-ETF-1.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Least Performing Reference</div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Asset:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Reference Asset with the lowest Percentage Change as compared to the Percentage Change of any other Reference Asset.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">4</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze1d51e332c0a4b9f80bba97db50d6fdc">

          <tr>
            <td style="width: 23%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Least Performing Percentage</div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Change:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Percentage Change of the Least Performing Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Monitoring Period:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Final Valuation Date Monitoring</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Trading Day:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">With respect to an Equity Reference Asset, a day on which the principal trading market(s) for such Reference Asset is scheduled to be open for trading, as determined by the Calculation
                Agent.</div>
              <div style="text-align: justify; margin-bottom: 3pt;">With respect to an Index Reference Asset, a day on which the NYSE and the Nasdaq Stock Market, or their successors, are scheduled to be open for trading, as determined by the Calculation
                Agent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Business Day:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized or required by law to close in New
                York City.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">U.S. Tax Treatment:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">By purchasing the Notes, you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to treat the Notes, for U.S.
                federal income tax purposes, as prepaid derivative contracts with respect to the Reference Assets. Pursuant to this approach, it is likely that any Contingent Interest Payment that you receive should be included in ordinary income at the
                time you receive the payment or when it accrues, depending on your regular method of accounting for U.S. federal income tax purposes. Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank,
                Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be reasonable to treat the Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is
                possible that your Notes could alternatively be treated for tax purposes as a single contingent payment debt instrument, as a constructive ownership transaction under Section 1260 of the Code (as defined herein)<font style="font-size: 8pt;">&#160;</font>or
                pursuant to some other characterization, such that the timing and character of your income from the Notes could differ materially and adversely from the treatment described above, as described further under &#8220;Material U.S. Federal Income Tax
                Consequences&#8221; herein and in the product supplements. <font style="font-weight: bold;">An investment in the Notes is not appropriate for non-U.S. holders and we will not attempt to ascertain the tax consequences to non-U.S. holders of the
                  purchase, ownership or disposition of the Notes.</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Tax Treatment:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Please see the discussion below under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; for information concerning the Canadian tax implications of an investment in the Notes</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Record Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Business Day preceding the relevant Contingent Interest Payment Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Calculation Agent:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Listing:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Bail-in:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Notes are not bail-inable debt securities (as defined in the prospectus) under the Canada Deposit Insurance Corporation Act.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Change in Law Event:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Not applicable, notwithstanding anything to the contrary in the applicable product supplement.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">5</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Additional Terms of Your Notes</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">You should read this pricing supplement together with the prospectus, as supplemented by the product supplement MLN-EI-1 and the product supplement MLN-ES-ETF-1
        (together, the &#8220;product supplements&#8221;) and the underlier supplement (the &#8220;underlier supplement&#8221;), relating to our Senior Debt Securities, Series H, of which these Notes are a part. Capitalized terms used but not defined in this pricing supplement
        will have the meanings given to them in the applicable product supplement. In the event of any conflict the following hierarchy will govern: first, this pricing supplement; second, the applicable product supplement; third, the underlier supplement;
        and last, the prospectus. <font style="font-weight: bold; font-style: italic;">The Notes vary from the terms described in the product supplements in several important ways. You should read this pricing supplement carefully.</font></div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">This pricing supplement, together with the documents listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements as well as any
        other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other
        things, the matters set forth in &#8220;Additional Risk Factors&#8221; herein, &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplements and &#8220;Risk Factors&#8221; in the prospectus, as the Notes involve risks not associated with conventional debt
        securities. We urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes. You may access these documents on the SEC website at www.sec.gov as follows (or if that address has changed, by
        reviewing our filings for the relevant date on the SEC website):</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="zecfeab4c8bf24d978aca689c53cbc0ae">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Prospectus dated February 26, 2025:</div>
              <div>
                <div style="margin-top: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
              </div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="z13757869dc8a44fcbd2c9cd5cb2be22e">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Underlier Supplement dated February 26, 2025:</div>
              <div>
                <div style="margin-top: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm</a></div>
              </div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="zd7958ab9c0f0476d9bcd05f2ca518e73">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Product Supplement MLN-EI-1 dated February 26, 2025:</div>
              <div>
                <div style="margin-top: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm</a></div>
              </div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="zc8c4a0263b8f43d6bf466c00a5905b02">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Product Supplement MLN-ES-ETF-1 dated February 26, 2025:</div>
              <div>
                <div style="margin-top: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006132/ef20044456_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006132/ef20044456_424b3.htm</a></div>
              </div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; font-family: Arial;">Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, the &#8220;Bank,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to The
        Toronto-Dominion Bank and its subsidiaries.</div>
      <div style="text-align: justify; font-family: Arial;">We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will notify you and you
        will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">6</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Additional Risk Factors</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The Notes involve risks not associated with an investment in conventional debt securities. This section describes the most significant risks relating to the terms of the Notes.
        For additional information as to these and other risks, please see &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplements and &#8220;Risk Factors&#8221; in the prospectus.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Investors should consult their investment, legal, tax, accounting and other advisors as to the risks entailed by an investment in the Notes and the suitability of the Notes in
        light of their particular circumstances.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to Return Characteristics</div>
      <div style="text-align: left; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Your Investment in the Notes May Result in a Loss.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The Notes do not guarantee the return of the Principal Amount and investors may lose up to their entire investment in the Notes. Specifically, if the Notes are not
        automatically called and the Final Value of any Reference Asset is less than its Barrier Value, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its
        Initial Value, and may lose the entire Principal Amount.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">You Will Not Receive the Contingent Interest Payment With Respect to a Contingent Interest Observation Date if the Closing Value of Any Reference Asset on
        Such Contingent Interest Observation Date Is Less Than Its Contingent Interest Barrier Value.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">You will not receive a Contingent Interest Payment on a Contingent Interest Payment Date if the Closing Value of any Reference Asset on the related Contingent Interest
        Observation Date is less than its Contingent Interest Barrier Value. If the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on each Contingent Interest Observation Date over the term of the Notes, you will
        not receive any Contingent Interest Payments and, therefore, you will not receive a positive return on your Notes. Generally, this non-payment of any Contingent Interest Payment will coincide with a greater risk of principal loss on your Notes at
        maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Potential Positive Return on the Notes Is Limited to the Contingent Interest Payments Paid on the Notes, if Any, Regardless of Any Appreciation of Any
        Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The potential positive return on the Notes is limited to any Contingent Interest Payments paid, meaning any positive return on the Notes will be composed solely of the sum of
        any Contingent Interest Payments paid over the term of the Notes. Therefore, if the appreciation of any Reference Asset exceeds the sum of any Contingent Interest Payments actually paid on the Notes, the return on the Notes will be less than the
        return on a hypothetical direct investment in such Reference Asset, in a security directly linked to the positive performance of such Reference Asset or a hypothetical investment in the stocks and other assets comprising such Reference Asset (its
        &#8220;Reference Asset Constituents&#8221;).</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Your Return May Be Less Than the Return on a Conventional Debt Security of Comparable Maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The return that you will receive on your Notes, which could be negative, may be less than the return you could earn on other investments. The Notes do not provide for fixed
        interest payments and you may not receive any Contingent Interest Payments over the term of the Notes. Even if you do receive one or more Contingent Interest Payments and your return on the Notes is positive, your return may be less than the return
        you would earn if you bought a conventional, interest-bearing senior debt security of TD of comparable maturity. Your investment may not reflect the full opportunity cost to you when you take into account factors that affect the time value of
        money.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Notes May Be Automatically Called Prior to the Maturity Date and Are Subject to Reinvestment Risk.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">If your Notes are automatically called, no further payments will be owed to you under the Notes after the applicable Call Payment Date. Therefore, because the Notes could be
        called as early as the first potential Call Payment Date, the holding period could be limited. There is no guarantee that you would be able to reinvest the proceeds from an investment in the Notes at a comparable return for a similar level of risk
        in the event the Notes are automatically called prior to the Maturity Date. Furthermore, to the extent you are able to reinvest such proceeds in an investment with a comparable return for a similar level of risk, you may incur transaction costs
        such as dealer discounts and hedging costs built into the price of the new notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Amounts Payable on the Notes Are Not Linked to the Value of the Least Performing Reference Asset at Any Time Other Than on the Contingent Interest
        Observation Dates (Including the Final Valuation Date) And Call Observation Dates.</div>
      <div style="text-align: justify; font-family: Arial;">Any payments on the Notes will be based on the Closing Value of the Least Performing Reference Asset only on the Contingent Interest Observation Dates (including the Final Valuation Date) and Call
        Observation Dates. Even if the value of the Least Performing Reference Asset appreciates prior to a Contingent Interest Observation Date but then drops on that day to a Closing Value that is less than its Contingent Interest Barrier Value, you will
        not receive any Contingent Interest Payment with respect to such Contingent Interest Observation Date. Similarly, the Payment at Maturity may be significantly less than it would have been had the Notes been linked to the Closing Value of the Least
        Performing Reference Asset on a date other than the Final Valuation Date, and may be zero. Although the actual values of the Reference Assets at other times during the term of the Notes may be higher than the values on one or more Contingent
        Interest Observation Dates (including the Final Valuation Date) or Call Observation Dates, any Contingent Interest Payments on the Notes and the Payment at Maturity will be based solely on the Closing Value of the Least Performing Reference Asset
        on the applicable Contingent Interest Observation Date (including the Final Valuation Date) and Call Observation Dates.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">7</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Contingent Interest Rate Will Reflect, in Part, the Volatility of Each Reference Asset and May Not Be Sufficient to Compensate You for the Risk of Loss
        at Maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Generally, the higher a Reference Asset&#8217;s volatility, the more likely it is that the Closing Value of that Reference Asset could be less than its Call Threshold Value or its
        Contingent Interest Barrier Value on a Call Observation Date or Contingent Interest Observation Date or its Barrier Value on its Final Valuation Date. Volatility means the magnitude and frequency of changes in the value of a Reference Asset. This
        greater risk will generally be reflected in a higher Contingent Interest Rate for the Notes than the interest rate payable on our conventional debt securities with a comparable term. However, while the Contingent Interest Rate is set on the Pricing
        Date, a Reference Asset&#8217;s volatility can change significantly over the term of the Notes, and may increase. The value of any Reference Asset could fall sharply on the Contingent Interest Observation Dates, resulting in few or no Contingent Interest
        Payments or on the Final Valuation Date, resulting in a loss of a significant portion or all of the Principal Amount.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">You Will Have No Rights to Receive Any Shares of Any Equity Reference Asset and You Will Not Be Entitled to Any Dividends or Other Distributions on Any
        Equity Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The Notes are our debt securities. They are not equity instruments, shares of stock, or securities of any other issuer. Investing in the Notes will not make you a holder of
        shares of any Equity Reference Asset. You will not have any voting rights, any rights to receive dividends or other distributions, or any rights against the issuer of any Equity Reference Asset. As a result, the return on your Notes may not reflect
        the return you would realize if you actually owned shares of any Reference Asset and received any dividends paid or other distributions made in connection with them. Your Notes will be paid in cash and you have no right to receive delivery of
        shares of any Reference Asset.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to Characteristics of the Reference Assets</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">There Are Market Risks Associated With Each Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The value of each Reference Asset can rise or fall sharply due to factors specific to such Reference Asset, its Reference Asset Constituents and their issuers (the &#8220;Reference
        Asset Constituent Issuers&#8221;) and, with respect to an Equity Reference Asset, its investment adviser (its &#8220;Investment Adviser&#8221;), such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments,
        management changes and decisions and other events, as well as general market factors, such as general stock market volatility and levels, interest rates and economic and political conditions. You, as an investor in the Notes, should make your own
        investigation into the Reference Assets for your Notes. For additional information, see &#8220;Information Regarding the Reference Assets&#8221; in this pricing supplement. <font style="font-weight: bold;">We urge you to review financial and other information
          filed periodically by any Investment Adviser with the SEC.</font></div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Investors Are Exposed to the Market Risk of Each Reference Asset on Each Contingent Interest Observation Date (Including the Final Valuation Date).</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Your return on the Notes is not linked to a basket consisting of the Reference Assets. Rather, it will be contingent upon the performance of each Reference Asset. Unlike an
        instrument with a return linked to a basket of indices, common stocks or other underlying securities, in which risk is mitigated and diversified among all of the components of the basket, you will be exposed equally to the risks related to each
        Reference Asset on each Contingent Interest Observation Date (including the Final Valuation Date). Poor performance by any Reference Asset over the term of the Notes will negatively affect your return and will not be offset or mitigated by a
        positive performance by any other Reference Asset. For instance, if the Final Value of any Reference Asset is less than its Barrier Value on its Final Valuation Date, you will receive a negative return equal to the Least Performing Percentage
        Change,<font style="font-size: 8pt;">&#160;</font>even if the Percentage Change of another Reference Asset is positive or has not declined as much. Accordingly, your investment is subject to the market risk of each Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Because the Notes Are Linked to the Least Performing Reference Asset, You Are Exposed to a Greater Risk of No Contingent Interest Payments and Losing a
        Significant Portion or All of Your Initial Investment at Maturity Than if the Notes Were Linked to a Single Reference Asset or Fewer Reference Assets.</div>
      <div style="text-align: justify; font-family: Arial;">The risk that you will not receive any Contingent Interest Payments and lose a significant portion or all of your initial investment in the Notes is greater if you invest in the Notes than the
        risk of investing in substantially similar securities that are linked to the performance of only one Reference Asset or fewer Reference Assets. With more Reference Assets, it is more likely that the Closing Value of any Reference Asset will be less
        than its Contingent Interest Barrier Value on any Contingent Interest Observation Date (including the Final Valuation Date) and that the Final Value of any Reference Asset will be less than its Barrier Value on the Final Valuation Date than if the
        Notes were linked to a single Reference Asset or fewer Reference Assets.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">8</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">In addition, the lower the correlation is between the performance of a pair of Reference Assets, the more likely it is that one of the Reference Assets will decline in value to
        a Closing Value or Final Value, as applicable, that is less than its Contingent Interest Barrier Value or Barrier Value on any Call Observation Date or Contingent Interest Observation Date (including the Final Valuation Date). Although the
        correlation of the Reference Assets&#8217; performance may change over the term of the Notes, the economic terms of the Notes, including the Contingent Interest Rate, Contingent Interest Barrier Value and Barrier Value are determined, in part, based on
        the correlation of the Reference Assets&#8217; performance calculated using our internal models at the time when the terms of the Notes are finalized. All things being equal, a higher Contingent Interest Rate and lower Contingent Interest Barrier Values
        and Barrier Values are generally associated with lower correlation of the Reference Assets. Therefore, if the performance of a pair of Reference Assets is not correlated to each other or is negatively correlated, the risk that you will not receive
        any Contingent Interest Payments or that the Final Value of any Reference Asset is less than its Barrier Value will occur is even greater despite a lower Contingent Interest Barrier Value and Barrier Value, respectively. Therefore, it is more
        likely that you will not receive any Contingent Interest Payments and that you will lose a significant portion or all of your initial investment at maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">We Have No Affiliation With Any Index Sponsor or Investment Adviser and Will Not Be Responsible for Any Actions Taken by Any Index Sponsor or Investment
        Adviser.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">No Index Sponsor or Investment Adviser is an affiliate of ours and no such entity will be involved in any offering of the Notes in any way. Consequently, we have no control of
        any actions of any Index Sponsor or Investment Adviser, including any actions of the type that could adversely affect the value of the applicable Reference Asset or any amounts payable on the Notes. No Index Sponsor or Investment Adviser has any
        obligation of any sort with respect to the Notes. Thus, no Index Sponsor or Investment Adviser has any obligation to take your interests into consideration for any reason, including in taking any actions that might affect the value of the Notes.
        None of our proceeds from any issuance of the Notes will be delivered to any Index Sponsor or Investment Adviser, except to the extent that we are required to pay an Index Sponsor licensing fees with respect to the applicable Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Value of an Equity Reference Asset May Not Completely Track Its NAV.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The net asset value (&#8220;NAV&#8221;) of an ETF, including an Equity Reference Asset, may fluctuate with changes in the market value of its Reference Asset Constituents. The market
        values of an ETF may fluctuate in accordance with changes in NAV and supply and demand on the applicable stock exchange(s). Furthermore, the Reference Asset Constituents may be unavailable in the secondary market during periods of market
        volatility, which may make it difficult for market participants to accurately calculate the intraday NAV per share of the applicable Equity Reference Asset and may adversely affect the liquidity and prices of such Equity Reference Asset, perhaps
        significantly. For any of these reasons, the market value of an Equity Reference Asset may differ from its NAV per share and may trade at, above or below its NAV per share.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Adjustments to an Equity Reference Asset Could Adversely Affect the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The Investment Adviser (as specified under &#8220;Information Regarding the Reference Assets&#8221;) for each Equity Reference Asset is responsible for calculating and maintaining the
        applicable Equity Reference Asset. An Investment Adviser can add, delete or substitute the Reference Asset Constituents for its Equity Reference Asset. An Investment Adviser may make other methodological changes to its Equity Reference Asset that
        could change the value of such Equity Reference Asset at any time. If one or more of these events occurs, the Closing Value of such Equity Reference Asset may be adjusted to reflect such event or events, which could adversely affect whether and the
        extent to which any amounts may be payable on the Notes and/or the market value of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Changes that Affect the Target Index of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF Will Affect the Market Value of, and Return on, the
        Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF is an ETF that seeks to provide investment results that, before fees and expenses, correspond generally to the
        price and yield performance of its Target Index (as specified herein). The policies of the sponsor of its Target Index (an &#8220;Index Sponsor&#8221;) concerning the calculation of its Target Index, additions, deletions or substitutions of the components of
        its Target Index and the manner in which changes affecting those components, such as stock dividends, reorganizations or mergers, may be reflected in its Target Index and, therefore, could adversely affect the return on the Notes and the market
        value of the Notes prior to maturity. The market value of, and return on, the Notes could also be affected if the sponsor of its Target Index changes these policies, for example, by changing the manner in which it calculates its Target Index. Some
        of the risks that relate to a target index of an ETF include those discussed in the product supplement, which you should review.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Performance of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF May Not Correlate With That of Its Target Index.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The performance of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF may not exactly replicate the performance of its Target Index because the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF will reflect transaction costs and fees that are not included in the calculation of its Target Index. It is also possible that the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF may not fully
        replicate or may in certain circumstances diverge significantly from the performance of its Target Index due to the temporary unavailability of certain securities in the secondary market, the performance of any derivative instruments contained in
        the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF, differences in trading hours between the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF and its Target Index or due to other circumstances.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">There Are Liquidity and Management Risks Associated with an ETF and the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF Utilizes a Passive Indexing
        Investment Approach.</div>
      <div style="text-align: justify; font-family: Arial;">&#160;Although shares of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF are listed for trading on a securities exchange and a number of similar products have been traded on various
        exchanges for varying periods of time, there is no assurance that an active trading market will</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">9</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">continue for such shares or that there will be liquidity in that trading market. The SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF is subject to management risk,
        which is the risk that its Investment Adviser&#8217;s investment strategy, the implementation of which is subject to a number of constraints, may not produce the intended results. Additionally, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking
        ETF is not managed according to traditional methods of &#8220;active&#8221; investment management, which involves the buying and selling of securities based on economic, financial and market analysis and investment judgment. Instead, utilizing a &#8220;passive&#8221; or
        indexing investment approach, it attempts to approximate the investment performance of its Target Index by investing in Reference Asset Constituents that generally replicate its Target Index. Therefore, unless a specific stock is removed from its
        Target Index, the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF generally would not sell a stock because that stock&#8217;s issuer was in financial trouble.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Notes Are Subject to Risks Associated With the Banking Sector.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The Notes are subject to risks associated with the banking sector because the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF is comprised of the stocks of companies
        whose primary lines of business are directly associated with the banking sector, which means that it will be more affected by the performance of the banking sector versus a fund that is more diversified. The performance of bank stocks may be
        affected by extensive governmental regulation which may limit both the amounts and types of loans and other financial commitments they can make, and the interest rates and fees they can charge and the amount of capital they must maintain.
        Profitability is largely dependent on the availability and cost of capital funds, and can fluctuate significantly when interest rates change. Credit losses resulting from financial difficulties of borrowers can negatively impact the sector. Banks
        may also be subject to severe price competition.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index Reflects Price Return, not Total Return.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The return on the Notes is based on the performance of the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index, which reflects the changes in the market prices of
        its Reference Asset Constituents. The Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is not a &#8220;total return&#8221; index or strategy, which, in addition to reflecting those price returns, would also reflect dividends paid on its
        Reference Asset Constituents. The return on the Notes will not include such a total return feature or dividend component.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Notes are Subject to Risks Associated with Small-Capitalization Companies.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The Notes are subject to risks associated with small-capitalization companies because the Reference Asset Constituents of the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index are considered
        small-capitalization companies. These companies often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization companies and therefore such index may be more volatile than an index in which a greater
        percentage of its constituents are issued by large-capitalization companies. Stock prices of small-capitalization companies are also more vulnerable than those of large-capitalization companies to adverse business and economic developments, and the
        stocks of small-capitalization companies may be thinly traded. In addition, small-capitalization companies are typically less stable financially than large-capitalization companies and may depend on a small number of key personnel, making them more
        vulnerable to loss of personnel. Small-capitalization companies are often given less analyst coverage and may be in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller revenues, less diverse
        product lines, smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization companies and are more susceptible to adverse developments related to their products.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to Estimated Value and Liquidity</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Estimated Value of Your Notes Is Less Than the Public Offering Price of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The estimated value of your Notes is less than the public offering price of your Notes. The difference between the public offering price of your Notes and the estimated value
        of the Notes reflects costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes. Because hedging our obligations entails risks and may be influenced by market forces beyond our
        control, this hedging may result in a profit that is more or less than expected, or a loss.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.</div>
      <div style="text-align: justify; font-family: Arial;">The estimated value of your Notes is determined by reference to our internal funding rate. The internal funding rate used in the determination of the estimated value of the Notes generally
        represents a discount from the credit spreads for our conventional, fixed-rate debt securities and the borrowing rate we would pay for our conventional, fixed-rate debt securities. This discount is based on, among other things, our view of the
        funding value of the Notes as well as the higher issuance, operational and ongoing liability management costs of the Notes in comparison to those costs for our conventional, fixed-rate debt, as well as estimated financing costs of any hedge
        positions, taking into account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional, fixed-rate debt securities, or the borrowing rate we would pay for our conventional, fixed-rate debt
        securities were to be used, we would expect the economic terms of the Notes to be more favorable to you. Additionally, assuming all other economic terms are held constant, the use of an internal funding rate for the Notes is expected to increase
        the estimated value of the Notes at any time.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">10</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Estimated Value of the Notes Is Based on Our Internal Pricing Models, Which May Prove to Be Inaccurate and May Be Different From the Pricing Models of
        Other Financial Institutions.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The estimated value of your Notes is based on our internal pricing models when the terms of the Notes are set, which take into account a number of variables, such as our
        internal funding rate on the Pricing Date, and are based on a number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different from other
        financial institutions&#8217; pricing models and the methodologies used by us to estimate the value of the Notes may not be consistent with those of other financial institutions that may be purchasers or sellers of Notes in the secondary market. As a
        result, the secondary market price of your Notes may be materially less than the estimated value of the Notes determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the future may
        change, and any assumptions may prove to be incorrect.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Estimated Value of Your Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, if Any, and Such Secondary
        Market Prices, if Any, Will Likely Be Less Than the Public Offering Price of Your Notes and May Be Less Than the Estimated Value of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The estimated value of the Notes is not a prediction of the prices at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you
        in secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market at any time, if any, will be influenced by many factors that
        cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the estimated value of the Notes. Further, as secondary market prices of your Notes take into account the levels
        at which our debt securities trade in the secondary market, and do not take into account our various costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes, secondary market
        prices of your Notes will likely be less than the public offering price of your Notes. As a result, the price at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market
        transactions, if any, will likely be less than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Temporary Price at Which the Agent May Initially Buy the Notes in the Secondary Market May Not Be Indicative of Future Prices of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market (if the
        Agent makes a market in the Notes, which it is not obligated to do) may exceed the estimated value of the Notes on the Pricing Date, as well as the secondary market value of the Notes, for a temporary period after the Issue Date of the Notes, as
        discussed further under &#8220;Additional Information Regarding the Estimated Value of the Notes.&#8221; The price at which the Agent may initially buy or sell the Notes in the secondary market may not be indicative of future prices of your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Underwriting Discount, Offering Expenses and Certain Hedging Costs Are Likely to Adversely Affect Secondary Market Prices.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Assuming no changes in market conditions or any other relevant factors, the price, if any, at which you may be able to sell the Notes will likely be less than the public
        offering price. The public offering price includes, and any price quoted to you is likely to exclude, any underwriting discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our obligations under
        the Notes. In addition, any such price is also likely to reflect dealer discounts, mark-ups and other transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge transaction.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">There May Not Be an Active Trading Market for the Notes &#8212; Sales in the Secondary Market May Result in Significant Losses.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">There may be little or no secondary market for the Notes. The Notes will not be listed or displayed on any securities exchange or electronic communications network. The Agent
        or another one of our affiliates may make a market for the Notes; however, it is not required to do so and may stop any market-making activities at any time. Even if a secondary market for the Notes develops, it may not provide significant
        liquidity or trade at prices advantageous to you. We expect that transaction costs in any secondary market would be high. As a result, the difference between bid and ask prices for your Notes in any secondary market could be substantial.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">If you sell your Notes before the Maturity Date, you may have to do so at a substantial discount from the public offering price irrespective of the value of the then-current
        least performing Reference Asset, and as a result, you may suffer substantial losses.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">If the Value of Any Reference Asset Changes, the Market Value of Your Notes May Not Change in the Same Manner.</div>
      <div style="text-align: justify; font-family: Arial;">Your Notes may trade quite differently from the performance of any of the Reference Assets. Changes in the value of any Reference Asset may not result in a comparable change in the market value of
        your Notes. Even if the Closing Value of each Reference Asset remains greater than or equal to its Barrier Value and Contingent Interest Barrier Value or increases to greater than its Call Threshold Value during the term of the Notes, the market
        value of your Notes may not increase by the same amount and could decline.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">11</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; margin-bottom: 6pt; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to Hedging Activities and Conflicts of Interest</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">There Are Potential Conflicts of Interest Between You and the Calculation Agent.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The Calculation Agent will, among other things, determine the amounts payable on the Notes. We will serve as the Calculation Agent and may appoint a different Calculation Agent
        after the Issue Date without notice to you. The Calculation Agent will exercise its judgment when performing its functions and may have a conflict of interest if it needs to make certain decisions. For example, the Calculation Agent may have to
        determine whether a market disruption event affecting a Reference Asset has occurred, and make certain adjustments if certain events occur, which may, in turn, depend on the Calculation Agent&#8217;s judgment as to whether the event has materially
        interfered with our ability or the ability of one of our affiliates to unwind our hedge positions. Because this determination by the Calculation Agent may affect the amounts payable on the Notes, the Calculation Agent may have a conflict of
        interest if it needs to make a determination of this kind. For additional information on the Calculation Agent&#8217;s role, see &#8220;General Terms of the Notes &#8212; Role of Calculation Agent&#8221; in the product supplements.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">You Will Have Limited Anti-Dilution Protection and, in Certain Situations, Your Return on the Notes May be Based on a Substitute Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The Calculation Agent may adjust the Initial Value, and therefore the Call Threshold Value, Contingent Interest Barrier Value and Barrier Value of an Equity Reference Asset for
        stock splits, reverse stock splits, stock dividends, extraordinary dividends and other events that affect such Equity Reference Asset, but only in the situations we describe in &#8220;General Terms of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the product
        supplement MLN-ES-ETF-1. The Calculation Agent will not be required to make an adjustment for every event that may affect an Equity Reference Asset. Furthermore, in certain situations, such as when a Reference Asset undergoes a Reorganization Event
        or a Reference Asset is delisted, such Reference Asset may be replaced by distribution property or a substitute equity security, as discussed more fully in the product supplement MLN-ES-ETF-1 under &#8220;General Terms of the Notes&#8221;. Notwithstanding the
        Calculation Agent&#8217;s ability to make adjustments to the terms of the Notes and the Reference Assets, those events or other actions affecting a Reference Asset, or a third party may nevertheless adversely affect the price of the applicable Reference
        Asset and, therefore, adversely affect the market value of, and return on, your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The Contingent Interest Observation Dates (Including the Final Valuation Date), Call Observation Dates and the Related Payment Dates Are Subject to Market
        Disruption Events and Postponements.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Each Contingent Interest Observation Date (including the Final Valuation Date), Call Observation Date and related payment date (including the Maturity Date) is subject to
        postponement due to the occurrence of one or more market disruption events. For a description of what constitutes a market disruption event as well as the consequences of that market disruption event, see &#8220;General Terms of the Notes &#8212; Market
        Disruption Events&#8221; in the product supplements. A market disruption event for a particular Reference Asset will not constitute a market disruption event for any other Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Trading and Business Activities by TD or Its Affiliates May Adversely Affect the Market Value Of, and Any Amounts Payable On, the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">We, the Agent and/or our other affiliates may hedge our obligations under the Notes by purchasing securities, futures, options or other derivative instruments with returns
        linked or related to changes in the value of a Reference Asset or one or more Reference Asset Constituents, and we may adjust these hedges by, among other things, purchasing or selling at any time any of the foregoing assets. It is possible that we
        or one or more of our affiliates could receive substantial returns from these hedging activities while the market value of the Notes declines. We or one or more of our affiliates may also issue or underwrite other securities or financial or
        derivative instruments with returns linked or related to changes in a Reference Asset or one or more Reference Asset Constituents.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">These trading activities may present a conflict between the holders&#8217; interest in the Notes and the interests we and our affiliates will have in our or their proprietary
        accounts, in facilitating transactions, including options and other derivatives transactions, for our or their customers&#8217; accounts and in accounts under our or their management. These trading activities could be adverse to the interests of the
        holders of the Notes.</div>
      <div style="text-align: justify; font-family: Arial;"><font style="color: rgb(0, 0, 0);">We, the Agent and/or our other affiliates may, </font>at present or in the future, engage in business with one or more Reference Asset Constituent Issuers,
        including making loans to or providing advisory services to those companies. These services could include investment banking and merger and acquisition advisory services. These business activities may present a conflict between <font style="color: rgb(0, 0, 0);">our, the Agent&#8217;s and/or our other affiliates&#8217; obligations</font>, and your interests as a holder of the Notes. Moreover, we, the Agent and/or our <font style="color: rgb(0, 0, 0);">other </font>affiliates may have published, and
        in the future expect to publish, research reports with respect to a Reference Asset or one or more Reference Asset Constituents. This research is modified from time to time without notice and may express opinions or provide recommendations that are
        inconsistent with purchasing or holding the Notes. Any of these activities by us and/or our <font style="color: rgb(0, 0, 0);">other </font>affiliates may affect the value of a Reference Asset and, therefore, the market value of, and any amounts
        payable on, the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">12</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; margin-bottom: 6pt; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to General Credit Characteristics</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Investors Are Subject to TD&#8217;s Credit Risk, and TD&#8217;s Credit Ratings and Credit Spreads May Adversely Affect the Market Value of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Although the return on the Notes will be based on the performance of the Least Performing Reference Asset, the payment of any amount due on the Notes is subject to TD&#8217;s credit
        risk. The Notes are TD&#8217;s senior unsecured debt obligations. Investors are dependent on TD&#8217;s ability to pay all amounts due on the Notes and, therefore, investors are subject to the credit risk of TD and to changes in the market&#8217;s view of TD&#8217;s
        creditworthiness. Any decrease in TD&#8217;s credit ratings or increase in the credit spreads charged by the market for taking TD&#8217;s credit risk is likely to adversely affect the market value of the Notes. If TD becomes unable to meet its financial
        obligations as they become due, investors may not receive any amounts due under the terms of the Notes.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-family: Arial; font-style: italic; font-weight: bold;">Risks Relating to Canadian and U.S. Federal Income Taxation</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">Significant Aspects of the Tax Treatment of the Notes Are Uncertain.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The U.S. tax treatment of the Notes is uncertain. Please read carefully the section entitled &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product
        supplements. You should consult your tax advisor as to the tax consequences of your investment in the Notes.</div>
      <div style="text-align: justify; font-family: Arial;"><font style="color: rgb(0, 0, 0);">For a discussion of the Canadian federal income tax consequences of investing in the Notes, please see the discussion below under &#8220;</font>Supplemental<font style="color: rgb(0, 0, 0);"> Discussion of Canadian Tax Consequences&#8221;. If you are not a Non-resident Holder (as that term is defined below under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221;) for Canadian federal income tax purposes or
          if you acquire the Notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Notes and receiving the payments that might be due under the Notes.</font></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">13</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Hypothetical Returns</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The examples set out below are included for illustration purposes only and are hypothetical examples only; amounts below may have been rounded for ease of analysis. The
        hypothetical Initial Values, Closing Values, Final Values and<font style="font-weight: bold;">&#160;</font>Percentage Changes of the Reference Assets used to illustrate the calculation of whether a Contingent Interest Payment is payable on a Contingent
        Interest Payment Date and the Payment at Maturity are not estimates or forecasts of the actual Initial Value, Closing Value or Final Value of any Reference Asset, or the value of any Reference Asset on any Trading Day prior to the Maturity Date.
        All examples assume, for Reference Asset A, Reference Asset B and Reference Asset C, respectively, Initial Values of $60.00, 25,000.00 and 2,500.00, Call Threshold Values of $60.00, 25,000.00 and 2,500.00 (each 100.00% of its Initial Value),
        Contingent Interest Barrier Values of $45.00, 18,750.00 and 1,875.00 (each 75.00% of its Initial Value), Barrier Values of $42.00, 17,500.00 and 1,750.00 (each 70.00% of its Initial Value), a Contingent Interest Payment of $8.833 per Note
        (reflecting the Contingent Interest Rate of approximately 10.60% per annum), that a holder purchased Notes with a Principal Amount of $1,000 and that no market disruption event occurs on any Call Observation Date or Contingent Interest Observation
        Date (including the Final Valuation Date). The actual terms of the Notes are set forth elsewhere in this pricing supplement.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Example 1 &#8212; The Closing Value of Each Reference Asset is Greater Than or Equal to its Call Threshold Value on the First Call Observation Date and the Notes are
        Automatically Called.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4a6b3cdd941b485e8d9b2b2c344c9f63">

          <tr>
            <td style="width: 24%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 29%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">First through Fifth Contingent Interest Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$44.165 (Aggregate Contingent Interest Payments &#8211; Not Callable)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">Sixth Contingent Interest Observation Date and First Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: $63.00 (<font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: 30,000.00 (<font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: 2,875.00 (<font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 6pt;">$1,000.00 (Principal Amount)</div>
              <div><u>+ $8.833</u> (Contingent Interest Payment)</div>
              <div>$1,008.833 (Total Payment upon Automatic Call)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;"><br>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,052.998 (5.2998% total return)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; font-family: Arial;">Because the Closing Value of each Reference Asset is greater than or equal to its Call Threshold Value (and therefore also greater than its Contingent Interest Barrier Value) on the first Call
        Observation Date (which is approximately 6 months after the Pricing Date), the Notes will be automatically called and, on the corresponding Call Payment Date, we will pay you a cash payment equal to $1,008.833 per Note, reflecting the Principal
        Amount plus the applicable Contingent Interest Payment. When added to the Contingent Interest Payments of $44.165 paid in respect of the prior Contingent Interest Payment Dates, TD will have paid you a total of $1,052.998 per Note, for a total
        return of 5.2998% on the Notes. No further amounts will be owed under the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">14</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: Arial; font-weight: bold;">Example 2 &#8212; The Closing Value of at Least One Reference Asset is Less Than its Contingent Interest Barrier Value on Each Contingent Interest Observation Date Prior to the Final
        Valuation Date, the Notes are NOT Automatically Called on Any Call Observation Date and the Final Value of Each Reference Asset is Greater Than or Equal to its Barrier Value and Contingent Interest Barrier Value.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7e8d3e74075546eebc88f7c30107ef79">

          <tr>
            <td style="width: 24%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 29%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">First through Fifth Contingent Interest Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold
                Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold
                Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">Sixth through Thirty-Fifth Contingent Interest Observation Date and First through Thirtieth Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">less than</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">Final Valuation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: $72.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: 26,250.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: 2,875.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 6pt;">$1,000.00 (Principal Amount)</div>
              <div><u>+ $8.833</u> (Contingent Interest Payment)</div>
              <div>$1,008.833 (Total Payment on Maturity Date)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;"><br>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,008.833 (0.8833% total return)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Because the Closing Value of at least one Reference Asset is less than its Contingent Interest Barrier Value on each Contingent Interest Observation Date prior to the Final
        Valuation Date (and therefore also less than its Call Threshold Value on each Call Observation Date), we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be
        automatically called. Because the Final Value of each Reference Asset is greater than or equal to its Barrier Value and Contingent Interest Barrier Value, on the Maturity Date we will pay you a cash payment equal to $1,008.833 per Note, reflecting
        your Principal Amount plus the applicable Contingent Interest Payment, for a total return of 0.8833% on the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">15</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: Arial; font-weight: bold;">Example 3 &#8212; The Closing Value of at Least One Reference Asset is Less Than its Contingent Interest Barrier Value on Each Contingent Interest Observation Date Prior to the Final
        Valuation Date, the Notes are NOT Automatically Called on Any Call Observation Date, the Final Value of Each Reference Asset is Greater Than or Equal to its Barrier Value and the Final Value of Any Reference Asset is Less Than its Contingent
        Interest Barrier Value.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdbef4b515bd043ca9afd3ee46fb76d5b">

          <tr>
            <td style="width: 24%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 29%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">First through Fifth Contingent Interest Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold
                Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">less than</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold
                Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">Sixth through Thirty-Fifth Contingent Interest Observation Date and First through Thirtieth Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">Final Valuation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: $42.00 (<font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value; <font style="font-weight: bold;">greater than or equal to</font> its Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: 23,750.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: 2,125.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,000.00 (Payment at Maturity)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;"><br>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,000.00 (0.00% total return)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Because the Closing Value of at least one Reference Asset is less than its Contingent Interest Barrier Value on each Contingent Interest Observation Date prior to the Final
        Valuation Date (and therefore also less than its Call Threshold Value on each Call Observation Date), we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be
        automatically called. Because the Final Value of each Reference Asset is greater than or equal to its Barrier Value and the Final Value of at least one Reference Asset is less than its Contingent Interest Barrier Value, on the Maturity Date we will
        pay you a cash payment equal to $1,000.00, reflecting your Principal Amount, for a total return of 0.00% on the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">16</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt; font-family: Arial; font-weight: bold;">Example 4 &#8212; The Closing Value of at Least One Reference Asset is Less Than its Contingent Interest Barrier Value on Each Contingent Interest Observation
        Date Prior to the Final Valuation Date, the Notes are NOT Automatically Called on Any Call Observation Date and the Final Value of At Least One Reference Asset is Less Than its Contingent Interest Barrier Value and Barrier Value.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9752b1ec32d4470298669875984a2653">

          <tr>
            <td style="width: 24%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 45%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 29%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">First through Fifth Contingent Interest Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value and Call Threshold Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold
                Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold
                Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">Sixth through Thirty-Fifth Contingent Interest Observation Date and First through Thirtieth Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all<font style="font-weight: bold;"> less than</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;">
              <div style="margin-top: 3pt;">Final Valuation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: $24.00 (<font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: 31,250.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: 2,750.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,000 + ($1,000 &#215; Least Performing Percentage Change) =</div>
              <div style="margin-top: 3pt;">$1,000 + ($1,000 &#215; -60.00%) =</div>
              <div style="margin-top: 3pt;">$400.00</div>
              <div style="margin-top: 3pt;">(Payment at Maturity)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 24%; vertical-align: top;"><br>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 29%; vertical-align: top;">
              <div style="margin-top: 3pt;">$400.00 (60.00% loss)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Because the Closing Value of at least one Reference Asset is less than its Contingent Interest Barrier Value on each Contingent Interest Observation Date prior to the Final
        Valuation Date (and therefore also less than its Call Threshold Value on each Call Observation Date), we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be
        automatically called. Because the Final Value of at least one Reference Asset is less than its Contingent Interest Barrier Value and Barrier Value, on the Maturity Date we will pay you a cash payment that is less than the Principal Amount, if
        anything, equal to the Principal Amount plus the product of the Principal Amount and the Least Performing Percentage Change,<font style="font-size: 8pt;">&#160;</font>for a total of $400.00 per Note, a loss of 60.00% per Note.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">In this scenario, investors will suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change. Specifically,
        investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Any payments on the Notes are subject to our credit risk.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">17</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Information Regarding the Reference Assets</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">All disclosures contained in this document regarding the Reference Assets, including, without limitation, their make-up, methods of calculation, and changes in any Reference
        Asset Constituents, have been derived from publicly available sources. We have not undertaken an independent review or due diligence of any publicly available information with respect to any Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Such information reflects the policies of, and is subject to change by, its Index Sponsor or Investment Adviser, as applicable. The Index Sponsor or Investment Adviser, as
        applicable, owns the copyright and all other rights to the relevant Reference Asset, has no obligation to continue to publish, and may discontinue publication of, the relevant Reference Asset. None of the websites referenced in the Reference Asset
        descriptions below, or any materials included in those websites, are incorporated by reference into this document or any document incorporated herein by reference. We have not independently verified the accuracy or completeness of reports filed by
        an Investment Adviser with the SEC, information published by it on its website or in any other format, information about it obtained from any other source or the information provided below.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The graphs below set forth the information relating to the historical performance of each Reference Asset. The graphs below show the daily historical Closing Values of each
        Reference Asset for the periods specified. We obtained the information regarding the historical performance of each Reference Asset in the graphs below from Bloomberg. The Closing Values for an Equity Reference Asset may be adjusted by Bloomberg
        for corporate actions such as stock splits, public offerings, mergers and acquisitions, spin-offs, delistings and bankruptcy.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of each Reference Asset should not be
        taken as an indication of its future performance, and no assurance can be given as to the Final Value of any Reference Asset. We cannot give you any assurance that the performance of the Reference Assets will result in a positive return on your
        initial investment.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="font-weight: bold; text-align: justify;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">We have derived all information contained herein regarding the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF (the &#8220;KRE Fund&#8221;) and the target index, as defined below,
        from publicly available information. Such information reflects the policies of, and is subject to changes by, the KRE Fund&#8217;s investment adviser, SSGA Funds Management, Inc. (&#8220;SSGA&#8221; or the &#8220;investment adviser&#8221;) and the index sponsor of the target
        index, as defined below.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The KRE Fund is one of the separate investment portfolios that constitute the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Series Trust (&#8220;SPDR&#8221;). The KRE Fund seeks to provide investment results that
        correspond generally to the total return performance, before fees and expenses, of the S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banks Select Industry Index (the &#8220;target index&#8221;). The target index seeks to measure the performance of the regional banks segment of
        the U.S. equity market and includes companies that have been identified as regional banks companies on the basis of general industry classification from a universe of companies defined by the S&amp;P Total Market Index, comprising the Regional
        Banks sub-industry. The target index is calculated, maintained and published by, S&amp;P Dow Jones Indices LLC (the &#8220;index sponsor&#8221;). The index sponsor is under no obligation to continue to publish, and may discontinue or suspend the publication
        of, the target index at any time.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Select information regarding the KRE Fund&#8217;s expense ratio and its top constituents, country, industry and/or sector weightings may be made available on the KRE Fund&#8217;s website.
        Expenses of the KRE Fund reduce the net asset value of the assets held by the KRE Fund and, therefore, reduce the value of the shares of the KRE Fund.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">SSGA uses a sampling strategy to manage the KRE Fund, an indexing investment strategy, which means that the KRE Fund is not required to purchase all of the securities represented
        in the target index. Instead, the KRE Fund may purchase a subset of the securities in the target index in an effort to hold a portfolio of securities with generally the same risk and return characteristics of the target index. The KRE Fund may or
        may not hold all of the securities that are included in the target index.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Under normal market conditions, the KRE Fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the target index. In addition,
        in seeking to track the target index, the KRE Fund may invest in equity securities that are not included in the target index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds (including
        money market funds advised by SSGA). In seeking to track the target index, the KRE Fund&#8217;s assets will generally be concentrated in an industry or group of industries to the extent that the target index concentrates in a particular industry or group
        of industries. Futures contracts may be used by the KRE Fund in seeking performance that corresponds to the target Index and in managing cash flows.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Shares of the KRE Fund are listed on the NYSE Arca under the ticker symbol &#8220;KRE&#8221;.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Information from outside sources including, but not limited to the prospectus related to the KRE Fund and any other website referenced in this section, is not incorporated by
        reference in, and should not be considered part of, this document or any document incorporated herein by reference. We have not undertaken an independent review or due diligence of any publicly available information with respect to the KRE Fund or
        the target index.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Information filed by SPDR with the SEC, including the prospectus for the KRE Fund, can be found by reference to its SEC file numbers: 333-57793 and 811-08839 or its CIK Code:
        0001064642.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">18</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: Arial; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The graph below illustrates the performance of KRE from October 16, 2015 through October 16, 2025. The dotted lines represent its Call Threshold Value of $58.14, which is equal to
        100.00% of its Initial Value, its Contingent Interest Barrier Value of $43.605, which is equal to 75.00% of its Initial Value, and its Barrier Value of $40.698, which is equal to 70.00% of its Initial Value</div>
      <div style="text-align: center; margin-top: 6pt; margin-bottom: 6pt; font-family: Arial; font-size: 10pt; font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Regional Banking ETF (KRE)</div>
      <div style="text-align: center; margin-bottom: 6pt;"><img src="image00004.jpg"></div>
      <div style="text-align: center; font-family: Arial; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">19</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; margin-bottom: 8pt; font-family: Arial; font-weight: bold;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="font-weight: bold;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">We have derived all information regarding the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (&#8220;NDX&#8221;) contained in this document, including, without limitation, its make-up, method of calculation
        and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by Nasdaq, Inc. and its affiliates (collectively, &#8220;Nasdaq&#8221;) (its &#8220;Index Sponsor&#8221; or &#8220;Nasdaq&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">NDX is published by Nasdaq, but Nasdaq has no obligation to continue to publish NDX, and may discontinue publication of NDX at any time. NDX is determined, comprised and
        calculated by Nasdaq without regard to this instrument.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8211; Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221;, NDX includes 100 of the largest domestic and international
        non-financial securities listed on the Nasdaq Stock Market<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> based on market capitalization. NDX includes companies across major industry groups including computer hardware and software, telecommunications, retail and wholesale trade, and
        biotechnology, but does not contain securities of financial companies, including investment companies.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">NDX is calculated under a modified capitalization-weighted methodology. The methodology is expected to retain in general the economic attributes of capitalization-weighting while
        providing enhanced diversification. To accomplish this, Nasdaq will review the composition of NDX on a quarterly basis and adjust the weightings of components using a proprietary algorithm, if certain pre-established weight distribution
        requirements are not met.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The graph below illustrates the performance of NDX from October 16, 2015 through October 16, 2025. The dotted lines represent its Call Threshold Value of 24,657.24, which is equal
        to 100.00% of its Initial Value, its Contingent Interest Barrier Value of 18,492.93, which is equal to 75.00% of its Initial Value, and its Barrier Value of 17,260.068, which is equal to 70.00% of its Initial Value.</div>
      <div style="text-align: center; margin-top: 6pt; margin-bottom: 6pt; font-family: Arial; font-size: 10pt; font-weight: bold;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (NDX)</div>
      <div style="text-align: center; margin-bottom: 6pt;"><img src="image00005.jpg"></div>
      <div style="text-align: center; font-family: Arial; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">20</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; margin-bottom: 8pt; font-family: Arial; font-weight: bold;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="font-weight: bold;">Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">We have derived all information regarding the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (&#8220;RTY&#8221;) contained in this document, including, without limitation, its make-up, method of calculation
        and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by the Frank Russell Company (the &#8220;Index Sponsor&#8221; or &#8220;FTSE Russell&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">RTY is published by FTSE Russell, but FTSE Russell has no obligation to continue to publish RTY, and may discontinue publication of RTY at any time. RTY is determined, comprised
        and calculated by FTSE Russell without regard to this instrument.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8211; The Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index,&#8221; RTY measures the composite price performance of the smallest
        2,000 companies included in the Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index. The Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is composed of the 3,000 largest United States companies by market capitalization and represents approximately 98% of the market capitalization of
        the United States equity market. Select information regarding top constituents and industry and/or sector weightings may be made available by the Index Sponsor on its website. RTY&#8217;s value is calculated by adding the market values of the underlying
        constituents and then dividing the derived total market capitalization by the &#8220;adjusted&#8221; capitalization of RTY on the base date of December 31, 1986.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The graph below illustrates the performance of RTY from October 16, 2015 through October 16, 2025. The dotted lines represent its Call Threshold Value of 2,467.015, which is equal
        to 100.00% of its Initial Value, its Contingent Interest Barrier Value of 1,850.2613, which is equal to 75.00% of its Initial Value, and its Barrier Value of 1,726.9105, which is equal to 70.00% of its Initial Value.</div>
      <div style="text-align: center; margin-top: 6pt; margin-bottom: 6pt; font-family: Arial; font-size: 10pt; font-weight: bold;">Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (RTY)</div>
      <div style="text-align: center; margin-bottom: 6pt;"><img src="image00006.jpg"></div>
      <div style="text-align: center; font-family: Arial; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">21</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; margin-bottom: 8pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Material U.S. Federal Income Tax Consequences</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial; font-weight: bold;">The U.S. federal income tax consequences of your investment in the Notes are uncertain. No statutory, regulatory, judicial or administrative authority
        directly discusses the characterization for U.S. federal income tax purposes of securities with terms that are substantially the same as the Notes. Some of these tax consequences are summarized below, but we urge you to read the more detailed
        discussion under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the product supplements and to discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of
        1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed U.S. Department of the Treasury (the &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change,
        possibly with retroactive effect. This discussion applies to you only if you are a U.S. holder, as defined in the product supplements. An investment in the Notes is not appropriate for non-U.S. holders and we will not attempt to ascertain the tax
        consequences to non-U.S. holders of the purchase, ownership or disposition of the Notes. Tax consequences under state, local and non-U.S. laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as
        to the U.S. federal income tax consequences of your investment in the Notes, and the following discussion is not binding on the IRS.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;"><font style="font-style: italic;">U.S. Tax Treatment.</font> Pursuant to the terms of the Notes, TD and you agree, in the absence of a statutory or regulatory change or an
        administrative determination or judicial ruling to the contrary, to treat the Notes as prepaid derivative contracts with respect to the Reference Assets. If your Notes are so treated, any Contingent Interest Payments paid on the Notes (including
        any Contingent Interest Payments paid with respect to a Call Payment Date or on the Maturity Date) would be treated as ordinary income includable in income by you in accordance with your regular method of accounting for U.S. federal income tax
        purposes. Holders are urged to consult their tax advisors concerning the significance, and the potential impact, of the above considerations.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Upon the taxable disposition (including cash settlement) of a Note, you generally should recognize gain or loss equal to the difference between the amount realized on such
        taxable disposition (adjusted for amounts or proceeds attributable to any accrued and unpaid Contingent Interest Payments, which would be treated as ordinary income) and your tax basis in the Note. Your tax basis in a Note generally should equal
        your cost for the Note. Subject to the &#8220;constructive ownership&#8221; rules of Section 1260 of the Code, discussed below, such gain or loss should generally be long-term capital gain or loss if you have held your Notes for more than one year (otherwise
        such gain or loss should be short-term capital gain or loss if held for one year or less).<font style="font-size: 8pt;">&#160;</font>The deductibility of capital losses is subject to limitations. Although uncertain, it is possible that proceeds received
        from the sale or exchange of your Notes prior to a Contingent Interest Payment Date, but that could be attributed to an expected Contingent Interest Payment, could be treated as ordinary income. You should consult your tax advisor regarding this
        risk.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;"><font style="font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is
          of the opinion that it would be reasonable to treat your Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be
          treated for tax purposes as a single contingent payment debt instrument, or pursuant to some other characterization (including possible treatment as a &#8220;constructive ownership transaction&#8221; under Section 1260 of the Code)</font><font style="font-size: 8pt;">,</font><font style="font-weight: bold;"> such that the timing and character of your income from the Notes could differ materially and adversely from the treatment described above, as described further under &#8220;Material U.S.
          Federal Income Tax Consequences &#8211; Alternative Treatments&#8221; in the product supplements.</font></div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;"><font style="font-style: italic;">Section 1260</font>. Because one or more Reference Assets would be treated as a &#8220;pass-thru entity&#8221; for purposes of Section 1260 of the Code,
        it is possible that an investment in the Notes could be treated as a &#8220;constructive ownership transaction&#8221; within the meaning of Section 1260 of the Code. If the Notes were treated as a constructive ownership transaction certain adverse U.S. federal
        income tax consequences could apply (i.e., all or a portion of any long-term capital gain that you recognize upon the taxable disposition of your Notes could be recharacterized as ordinary income and you could be subject to an interest charge on
        deferred tax liability with respect to such recharacterized gain). We urge you to read the discussion concerning the possible treatment of the Notes as a constructive ownership transaction under &#8220;Material U.S. Federal Income Tax Consequences &#8211;
        Section 1260&#8221; in the product supplement.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Except to the extent otherwise required by law, TD intends to treat your Notes for U.S. federal income tax purposes in accordance with the treatment described above and under
        &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the product supplements, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;"><font style="font-style: italic;">Section 1297</font>. We will not attempt to ascertain whether any Reference Asset Constituent Issuer or the issuer of any ETF Reference Asset,
        as applicable,<font style="font-size: 8pt;">&#160;</font>would be treated as a passive foreign investment company (&#8220;PFIC&#8221;) within the meaning of Section 1297 of the Code. If any such entity were so treated, certain adverse U.S. federal income tax
        consequences might apply upon the taxable disposition of a Note. You should refer to information filed with the SEC or the equivalent governmental authority by such entities and consult your tax advisors regarding the possible consequences to you
        if any such entity is or becomes a PFIC.</div>
      <div style="text-align: justify; font-family: Arial;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of holders of the Notes. According to Notice 2008-2, the IRS and the
        Treasury are considering whether the holder of an instrument such as the Notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible,
        however, that under such guidance, holders of the Notes will ultimately be required to accrue current income, possibly in excess of any Contingent Interest Payments received by such holders, and this could be applied on a retroactive basis.
        According to the Notice, the IRS and the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital and whether the special &#8220;constructive ownership
        rules&#8221; of Section 1260 of the Code (discussed above) should be</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">22</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">applied to such instruments. You are urged to consult your tax advisor concerning the significance, and the potential impact, of the above considerations.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;"><font style="font-style: italic;">Medicare Tax on Net Investment Income. </font>U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8%
        tax on all or a portion of their &#8220;net investment income&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the Notes, to the extent of their net investment
        income or undistributed net investment income (as the case may be) that when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving
        spouse), $125,000 for a married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the income tax. You should
        consult your tax advisor as to the consequences of the 3.8% Medicare tax.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;"><font style="font-style: italic;">Specified Foreign Financial Assets. </font>U.S. holders may be subject to reporting obligations with respect to their Notes if they do not
        hold their Notes in an account maintained by a financial institution and the aggregate value of their Notes and certain other &#8220;specified foreign financial assets&#8221; (applying certain attribution rules) exceeds an applicable threshold. Significant
        penalties can apply if a U.S. holder is required to disclose its Notes and fails to do so.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;"><font style="font-style: italic;">Backup Withholding and Information Reporting.</font> The proceeds received from a taxable disposition of the Notes will be subject to
        information reporting unless you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you are a
        U.S. holder) or meet certain other conditions.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;"><font style="font-style: italic;">Proposed Legislation. </font>In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of
        Notes purchased after the bill was enacted to accrue interest income over the term of the Notes despite the fact that there may be no interest payments over the term of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the
        effect of this legislation generally would have been to require instruments such as the Notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">It is impossible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your Notes. You are
        urged to consult your tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Notes.</div>
      <div style="text-align: justify; font-family: Arial; font-weight: bold;">You are urged to consult your tax advisor concerning the application of U.S. federal income tax laws to an investment in the Notes, as well as any tax consequences of the
        purchase, beneficial ownership and disposition of the Notes arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of TD and those of the Reference Asset Constituent Issuers).</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">23</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Supplemental Discussion of Canadian Tax Consequences</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">The following section supersedes and replaces in its entirety the section of the product supplements under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the section
        &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; in the prospectus.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">In the opinion of Osler, Hoskin &amp; Harcourt LLP, special Canadian tax counsel to TD, the following is, as of the date hereof, a summary of certain Canadian federal income tax
        considerations under the Income Tax Act (Canada) (the &#8220;Canadian Tax Act&#8221;) and Income Tax Regulations issued thereunder (the &#8220;Canadian Tax Regulations&#8221;) generally applicable to a holder who acquires beneficial ownership of a Note pursuant to this
        pricing supplement, and who, for purposes of the Canadian Tax Act and any applicable income tax convention, at all relevant times, is not resident and is not deemed to be resident in Canada, and who, for purposes of the Canadian Tax Act, at all
        relevant times, (i) deals at arm&#8217;s length with TD and any Canadian resident (or deemed Canadian resident) to whom the holder disposes of the Note, (ii) is entitled to receive all payments (including any interest and principal) made on the Note as
        beneficial owner, (iii) is not, and deals at arm&#8217;s length with each person who is, a &#8220;specified shareholder&#8221; of the Issuer for purposes of the thin capitalization rules in the Canadian Tax Act, (iv) is not an entity in respect of which TD is a
        &#8220;specified entity&#8221; for purposes of the rules regarding &#8220;hybrid mismatch arrangements&#8221; (both as defined in the Canadian Tax Act), (v) holds the Note as capital property, (vi) does not use or hold and is not deemed to use or hold the Note in or in
        the course of carrying on a business in Canada and (vii) is not an insurer carrying on an insurance business in Canada and elsewhere (a &#8220;Non-resident Holder&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">This summary is based upon the current provisions of the Canadian Tax Act and the Canadian Tax Regulations in force as of the date hereof, all specific proposals to amend the
        Canadian Tax Act and the Canadian Tax Regulations publicly announced by or on behalf of the Minister of Finance (Canada) prior to the date hereof (the &#8220;Tax Proposals&#8221;) and counsel&#8217;s understanding of the current administrative policies and assessing
        practices of the Canada Revenue Agency (&#8220;CRA&#8221;) published in writing by the CRA prior to the date hereof. This summary is not exhaustive of all possible Canadian federal income tax considerations relevant to an investment in the Notes and, except
        for the Tax Proposals, does not take into account or anticipate any changes in law or CRA administrative policies or assessing practices, whether by way of legislative, governmental or judicial decision or action, nor does it take into account or
        consider any other federal tax considerations or any provincial, territorial or non-Canadian tax considerations, which may differ materially from those discussed herein. While this summary assumes that the Tax Proposals will be enacted in the form
        proposed, no assurance can be given that this will be the case, and no assurance can be given that judicial, legislative or administrative changes will not modify or change the statements below.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">This summary assumes that no amount paid or payable to a holder described herein will be the deduction component of a &#8220;hybrid mismatch arrangement&#8221; under which the payment arises
        within the meaning of paragraph 18.4(3)(b) of the Canadian Tax Act.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">The following is only a general summary of certain Canadian non-resident withholding and other tax provisions which may affect a Non-resident Holder of the
        Notes described in this pricing supplement. This summary is not, and is not intended to be, and should not be construed to be, legal or tax advice to any particular Non-resident Holder and no representation with respect to the income tax
        consequences to any particular Non-resident Holder is made. Persons considering investing in Notes should consult their own tax advisors with respect to the tax consequences of acquiring, holding and disposing of Notes having regard to their own
        particular circumstances.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial;">Based in part on the published administrative position of the CRA, any amount in excess of the Principal Amount of a Note paid or credited or deemed for purposes of the Canadian
        Tax Act to be paid or credited to a Non-resident Holder on the Note should not be subject to Canadian non-resident withholding tax. Should payments with respect to the Notes become subject to such withholding tax, TD will withhold tax at the
        applicable statutory rate and will not make payments of any additional amounts.</div>
      <div style="text-align: justify; margin-top: 6pt; font-family: Arial; font-weight: bold;">GENERALLY, THERE ARE NO OTHER CANADIAN TAXES ON INCOME (INCLUDING TAXABLE CAPITAL GAINS) PAYABLE BY A NON-RESIDENT HOLDER UNDER THE CANADIAN TAX ACT SOLELY AS A
        CONSEQUENCE OF THE ACQUISITION, OWNERSHIP OR DISPOSITION OF A NOTE.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">24</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Supplemental Plan of Distribution (Conflicts of Interest)</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; font-family: Arial;">We have appointed TDS, an affiliate of TD, as the Agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, TDS will purchase the
        Notes from TD at the public offering price less the underwriting discount specified on the cover page hereof and will use all of that commission to allow selling concessions to other registered broker-dealers in connection with the distribution of
        the Notes. The underwriting discount represents the selling concessions for other dealers in connection with the distribution of the Notes. The Notes were generally offered to the public at the public offering price, provided that certain fee based
        advisory accounts may have agreed to purchase the Notes for as low as the price specified on the cover hereof and such registered broker-dealers may have agreed to forgo, in their sole discretion, some or all of their selling concessions in
        connection with such sales. TD will also periodically pay one or more unaffiliated dealers a structuring fee and/or marketing fee per Note in the amount indicated on the cover hereof with respect to all of the Notes. We or one of our affiliates
        will also pay a fee to iCapital Markets LLC, who is acting as a dealer in connection with the distribution of the Notes. TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS
        a fee in connection with its role in the offer and sale of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;"><font style="font-style: italic;">Conflicts of Interest. </font>TDS is an affiliate of TD and, as such, has a &#8216;&#8216;conflict of interest&#8217;&#8217; in this offering within the meaning of
        Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. If any other affiliate of TD participates in this offering, that affiliate will also have a &#8220;conflict of interest&#8221; within the meaning of FINRA Rule 5121. In addition, TD will
        receive the net proceeds from the initial public offering of the Notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. This offering of the Notes will be conducted in compliance with the provisions of FINRA
        Rule 5121. In accordance with FINRA Rule 5121, neither TDS nor any other affiliate of ours is permitted to sell the Notes in this offering to an account over which it exercises discretionary authority without the prior specific written approval of
        the account holder.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">We, TDS, another of our affiliates or third parties may use this pricing supplement in the initial sale of the Notes. In addition, we, TDS, another of our affiliates or third
        parties may use this pricing supplement in a market-making transaction in the Notes after their initial sale. <font style="font-weight: bold; font-style: italic;">If a purchaser buys the Notes from us, TDS, another of our affiliates or third
          parties, this pricing supplement is being used in a market-making transaction unless we, TDS, another of our affiliates or third parties informs such purchaser otherwise in the confirmation of sale.</font></div>
      <div style="text-align: justify; margin-top: 3pt; font-family: Arial; font-weight: bold;">Prohibition on Sales to EEA Retail Investors</div>
      <div style="text-align: justify; margin-top: 3pt; font-family: Arial;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European
        Economic Area (the &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); (ii) a customer within the
        meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended.
        Consequently no key information document required by Regulation (EU) No 1286/2014 (the &#8220;EU PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore
        offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</div>
      <div style="text-align: justify; margin-top: 3pt; font-family: Arial; font-weight: bold;">Prohibition on Sales to United Kingdom Retail Investors</div>
      <div style="text-align: justify; margin-top: 3pt; font-family: Arial;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United
        Kingdom (&#8220;UK&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union
        (Withdrawal) Act 2018 (the &#8220;EUWA&#8221;); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the &#8220;FSMA&#8221;) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that
        customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU)
        No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling
        the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">25</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Additional Information Regarding the Estimated Value of the Notes</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; font-family: Arial;">The final terms for the Notes were determined on the Pricing Date, based on prevailing market conditions, and are specified elsewhere in this pricing
        supplement.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">The economic terms of the Notes are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks and our appetite for
        borrowing), and several factors, including any sales commissions expected to be paid to TDS or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated intermediaries, the
        estimated profit that we or any of our affiliates expect to earn in connection with structuring the Notes, estimated costs which we may incur in connection with the Notes and the estimated cost which we may incur in hedging our obligations under
        the Notes. Because our internal funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our
        benchmark debt securities trade in the secondary market is expected to have had an adverse effect on the economic terms of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">On the cover page of this pricing supplement, we have provided the estimated value for the Notes. The estimated value was determined by reference to our internal pricing models
        which take into account a number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates), price-sensitivity analysis, time to
        maturity of the Notes and our internal funding rate. For more information about the estimated value, see &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; herein. Because our internal funding rate generally represents a
        discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt securities trade in the secondary market is
        expected, assuming all other economic terms are held constant, to increase the estimated value of the Notes. For more information see the discussion under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity &#8212; The Estimated
        Value of Your Notes Is Based on Our Internal Funding Rate.&#8221;</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Our estimated value of the Notes is not a prediction of the price at which the Notes may trade in the secondary market, nor will it be the price at which the Agent may buy or
        sell the Notes in the secondary market. Subject to normal market and funding conditions, the Agent or another affiliate of ours intends to offer to purchase the Notes in the secondary market but it is not obligated to do so.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-family: Arial;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market, if any, may
        exceed our estimated value on the Pricing Date for a temporary period expected to be approximately 3 months after the Issue Date because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of
        hedging our obligations under the Notes and other costs in connection with the Notes which we will no longer expect to incur over the term of the Notes. We made such discretionary election and determined this temporary reimbursement period on the
        basis of a number of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated costs which we effectively reimburse to investors in this way may not be allocated ratably
        throughout the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Issue Date of the Notes based on changes in market conditions and other factors that cannot be
        predicted.</div>
      <div style="text-align: justify; margin-top: 12pt; font-family: Arial; font-weight: bold;">We urge you to read the &#8220;Additional Risk Factors&#8221; herein.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">26</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; margin-bottom: 6pt; color: rgb(0, 176, 80); font-family: Arial; font-size: 16pt;">Validity of the Notes</div>
      <div style="text-align: justify; margin-top: 12pt; margin-bottom: 6pt; font-family: Arial;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special products counsel to TD, when the Notes offered by this pricing supplement have
        been executed and issued by TD and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the Notes will be valid and binding obligations of TD, enforceable against TD in accordance with
        their terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity (regardless of
        whether enforcement is sought in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law, Fried, Frank,
        Harris, Shriver &amp; Jacobson LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by McCarthy T&#233;trault LLP, Canadian legal counsel for TD, in its opinion expressed below. In addition, this opinion
        is subject to customary assumptions about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the Notes, authentication of the Notes and the genuineness of signatures and certain factual matters, all as stated
        in the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP filed as Exhibit 5.3 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div style="text-align: justify; margin-top: 12pt; font-family: Arial;">In the opinion of McCarthy T&#233;trault LLP, the issue and sale of the Notes has been duly authorized by all necessary corporate action on the part of TD, and when this pricing
        supplement has been attached to, and duly notated on, the master note that represents the Notes, the Notes will have been validly executed and issued and, to the extent validity of the Notes is a matter governed by the laws of the Province of
        Ontario, or the laws of Canada applicable therein, will be valid obligations of TD, subject to the following limitations: (i) the enforceability of the indenture is subject to bankruptcy, insolvency, reorganization, arrangement, winding up,
        moratorium and other similar laws of general application limiting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the fact that the availability of
        equitable remedies, such as injunctive relief and specific performance, is in the discretion of a court; (iii) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada; and (iv) the enforceability
        of the indenture will be subject to the limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the indenture to be unenforceable as an attempt to vary or
        exclude a limitation period under that Act. This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable thereto. In addition, this opinion is subject to: (i) the
        assumption that the senior indenture has been duly authorized, executed and delivered by, and constitutes a valid and legally binding obligation of, the trustee, enforceable against the trustee in accordance with its terms; and (ii) customary
        assumptions about the genuineness of signatures and certain factual matters all as stated in the letter of such counsel dated December 20, 2024, which has been filed as Exhibit 5.2 to the registration statement on Form F-3 filed by TD on December
        20, 2024.</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">27</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Oct 17 01:48:00 UTC 2025 -->
<!--?xml version="1.0" encoding="ASCII"?-->
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 04 23:02:01 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->



<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: Arial; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);"><div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-bottom: 20px;">

      <div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;">Calculation of Filing Fee Tables</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-32">F-3</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-33">TORONTO DOMINION BANK</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 12pt; font-weight: bold;">Narrative Disclosure</div>
        <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>

        <ix:nonNumeric contextRef="c0" escape="true" name="ffd:NrrtvDsclsr" id="ixv-26"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-34">508,000.00</ix:nonFraction></span>. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-35">final prospectus</ix:nonNumeric> for the related offering.</div></ix:nonNumeric><div><br/>
        </div>
      </div>
    </div>
  </div></div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-38">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-39">0000947263</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-40">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OfferingTableNa" id="ixv-41">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-42">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-43">333-283969</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-44">424B2</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<!-- [WMV6][hCQSVAuKnp/0INH1/1zphMZddlGq0tx9f4Ri7PIO/JhDMbtW8iZ+bBF1eQS3SoKH1S57JCU7CeLCWs8F19wW6lN79C+0tRNQQtZt/dXBWQ8fsuX2s/uiVF15TZ5t37x69Aoqj9XEwMekjJ9rh0S7pPjMWGoIs0R+cKA7uYxhxYs5qNxoEaHm2anOiXlpaaFGE+tU57za3nGPHqzE1kYR/anfTIwDxcOr8f/McJoaqjoonuQPubZcEQBmIQBIGjlui4sCo5D9d1xHsX2m5b8XMvgVikFzNpKh9GnGMW+WkBpKRAacatePuo7vnCTK997hkN3zq4RF5/qeIXKMa/ZDWK3qqoqjvFvaO/BZzJKYgjT2HRXbgVc36v3r9f6DtvMJptjOTSqqCweoYBqegpeJ9Sq13FujnpYQV5S4rZb5vJ/ka9tKkep3G6HdQ1YqCh8/lSOoJ8bgdmtasCgWHjw=] CSR-->
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000947263</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-10-16</xbrli:startDate>
    <xbrli:endDate>2025-10-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) %$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#YWHHKW[1O
MV4/VI?$>CZ5XA\/?LU_'[7= UW3;'6=#US1O@Y\1-4T?6='U2UBOM-U72M2L
MO#D]EJ.FZC93PW=C?6DTUK=VLT5Q;RR12(Y_RXPV#QF-E*.#PF)Q<H)2G'#4
M*M>4(MV4I*E";BF]$VDKZ'_,QEV3YOG$ZE/*,JS'-*E&*G6IY=@<5CITH2ER
MQG4AAJ564(RE[JE)).6B=SP&BOI#_AC?]KS_ *-6_:0_\,=\3O\ YEZ/^&-_
MVO/^C5OVD/\ PQWQ._\ F7KL_L+//^A-FO\ X;L7_P#*3U_]2.-/^B0XH_\
M#!FO_P R>:^\^;Z*^D/^&-_VO/\ HU;]I#_PQWQ._P#F7H_X8W_:\_Z-6_:0
M_P##'?$[_P"9>C^PL\_Z$V:_^&[%_P#RD/\ 4CC3_HD.*/\ PP9K_P#,GFOO
M/F^BOI#_ (8W_:\_Z-6_:0_\,=\3O_F7KR7QY\-/B/\ "O6+;P]\3_A_XV^'
M&OWFFPZS::'X\\*:[X0UBZT>XNKRQM]5MM-\0V&G7L^FSWNG:A:0WT4+6LMU
M8WENDK2VTR)CB,KS/"4W6Q678_#4DU%U<1@\11IJ4M(ISJ4XQ3?17N^AQ8_A
MKB3*\.\7F?#^=Y=A5*,'B<?E6/PF'4YZ0@ZV(H4Z:E-_#%RO+HF<31117 >(
M%%%% !7].WP"_P""TW[+?PK^!/P5^&'B'P%\?KS7_AQ\)?AQX#UR[T;PM\.[
MC1[K6/"'@[1O#VI7.E7%]\5-.O9]-GO=.FEL9KO3[&ZEM6B>XL[:5GA3^8FB
MOKN$>-L]X)Q.+Q615,-3JXZA##UWB<-'$1=.G4]I'EC)KE?-NUNM#]6\*?&;
MC;P9S#-LSX)KY=0Q6=8.A@,<\QR^GF$)8?#U_K%-4X5)P5.7M-Y*[<=#^SS]
MG7_@K5^SE^TU\9/!WP0\!^"OC9I/BOQM_P )!_96H>+O#G@6P\/6_P#PC?A;
M7/%U]_:%WHWQ(U_4HO-TW0+R"T^S:3=^9?26T<WD0/+<P_J)7\3_ /P2._Y2
M%?L^_P#=5_\ U2/Q)K^V"O[+\'N+\YXTX9QV:9Y/#U,7A\]Q.7TWAJ$</!8>
MEE^68B"<(MIS]IBJK<KW:<5]D_U_^B3XL<7^,7AQG7$W&E; 5\TP/&V99%AY
MY?@88"BLOPN0\-YA2C*C3E.,JOUG,\4Y56[N,H0M:"/R[\(_\%3/"'Q \/:?
MXN\!_L=?M^>-O"FK?:_[*\3^$?V>],\2>'M3^P7USIE]_9^M:-\0KW3;W[%J
M5E>:?=_9KF3[-?6ES:3;)X)8TYOX@_\ !7[X0_"7^R/^%J_LR?ML?#+_ (2#
M[?\ V#_PL'X,>&/!G]M_V5]B_M3^R/\ A(_B9IO]I?V;_:6G?;_L?G?8_M]E
M]H\O[5!YGI'_  2._P"4>O[/O_=5_P#U=WQ)K\W_ /@X*_YM(_[KU_[Q>O%S
MSB'C'*?#2AQU3X@P]7%U<GX>S)X">2X..'4\YJY93JTE4C4]KR45CINF]Y.G
M'FW9\=QIQ[XN<+?1SP?C;A^/,!BLTQ/"? /$4LDK<'93#+XU^,,5PWA\3AEB
M(5_K#I8-9W6E0FUSU'1IJ=DY'TA_P_B_9#_Z)S^TA_X2'PQ_^?!7Z9?!7XU_
M!?\ ; ^"\'CKP+/IOC7X>>-=-U'PWXJ\*^)-.L+JZTRZNK!+;Q1\//B'X7N7
MU&R@U*"RU%;75](NFU#1]9T?4+35M)N];\+:WI.K:E_G^U^\W_! [QYK&G?'
M;XX_#"&VTUM \7_"73O'FI7<L-TVL0:Q\./&.E>'M#MK&X2\2RBTVZLOBIXA
MEU6&XT^YNI[JST9[2\L8K>]AU'X/PY\9^)<^XKR_(>(H8#%8#-_;8-2H818>
MKA\0Z-2I0G:+G&M2JSI_5ZU*<4E&LJRFO9.G5_#?H^?3"\1>.?%#(>!_$"CD
M.9Y%Q9];RF-3!95' XG 9A+!U\1@JKC2G5I8S"XJK0_L_%X:O3BHT\6L7&M%
M86>'Q)_P5P_X)U>!O@5H]K^TE\!?#^I:-X.\0>-KNQ^*G@JP\RY\*> ;KQ':
MV!\+:SX.TC3?#2Q>$/!-]K]GKVGZY%K?B<Z/I7B7Q5X(\,>"-*TS2+NVT?3O
MP9K^][]MW1M(UW]CG]J2QUS2M-UFR@^ /Q8UF&TU6QM=1M8=8\.>"=:\0^'M
M5BM[N*:*/4M"U_2]-US1KY$%UI>L:=8ZE8RP7MI;S1_P0U\1XZ<*Y=PWQ5A\
M1E5&EA,+G>">-G@J%-4J.&Q5*K*AB'0IPM"G2KVIUO9P2C"K*MRJ,'"*_&/I
MM^&'#WAYXGY?F'#&$PN5Y9QGD[SBMD^"H1PV#P&:87%3P>/G@Z%)1HT,+CDL
M/B_84HPA3Q4\7R0A2E2A$HHHK\3/XT"BBB@#](/^"1W_ "D*_9]_[JO_ .J1
M^)-?VP5_$_\ \$CO^4A7[/O_ '5?_P!4C\2:_M@K^TOHY?\ )$9I_P!E5CO_
M %49&?[%_L]O^3,<3?\ 9S\Z_P#64X*/S?\ ^"1W_*/7]GW_ +JO_P"KN^)-
M?F__ ,'!7_-I'_=>O_>+U^D'_!([_E'K^S[_ -U7_P#5W?$FOS?_ .#@K_FT
MC_NO7_O%Z.,?^4>\'_V2O O_ *D\/!XN_P#* V4_]FP\$?\ U9< G\W]?I!_
MP2._Y2%?L^_]U7_]4C\2:_-^OWX_X()_"KQ?=?%[XQ?&_P"Q?9_ 6A_#>7X5
M?VA=6^J0_P!L>+_%7B?PCXN^QZ'=_P!G-HVH?\(YHW@[S_%5O_:T.IZ/_P )
M5X-D_LZXM-<^TVO\S^&>7ULSX^X3H45-NAG6"S&HX4W4Y:.5UHYC5<ES148.
M&&<)5&_<YE)1FTH2_P X?HX9!B^(_'3PMP6#C5<L'QEDV?UY4J#K^SPG#6+I
MY_BI5%STU3I2HY;*E.O*=J/M%-0K34:-3^G;6=&TCQ'H^J^'O$.E:;KN@:[I
MM]HVN:'K-C:ZIH^LZ/JEK+8ZEI6JZ;?13V6HZ;J-E/-:7UC=PS6MW:S2V]Q%
M)%(Z'_.1K^][]MGXCVOPF_9'_:*\=3^)=2\'WNG?"7QCI7AKQ)HSZQ!K&E^.
M?%FE3>$/A]+I5[H,<FJ:7J4WCC7?#UK8ZS;M;QZ+=3Q:M=WVG65G<7]M_!#7
M[#])7%T)YCPI@8J/UG#8+-,75:E#G]AC:^#HX=2BOWBBJF Q7)*2Y)-S4/>C
M4M_6W[1C-<%6X@\+LDIQI?VCE^3<39IBI*=)UW@LXQN483 *I37[^%*-?(\R
M=&=1>RJ3E7C1O.E7L4445_,A_FX%%%% 'Z0?\$CO^4A7[/O_ '5?_P!4C\2:
M_M@K_.C\(^,O%_P_\0Z?XN\!^*O$G@GQ7I/VO^RO$_A'7-4\-^(=,^WV-SIE
M]_9^M:-=66I67VW3;V\T^[^S7,?VFQN[FTFWP3RQO[9_PV1^UY_T=3^TA_X?
M'XG?_-17[MX8>+F7<!9!C,GQ>48W'U,3G&(S*-;#5Z%*$85L%E^%5)QJIR<U
M+!RDVM+3BMTS^WOHU?2LX?\  S@7-N$LVX4SG/<1F/%N.XBAB\NQN"PU&G0Q
M>3Y#ED<-*&)3J.K">45:LIKW'&M3BM5(_K0_X)'?\H]?V??^ZK_^KN^)->D?
MMB?L'?"']MO_ (5U_P +5\1_$CP__P *R_X2[^P?^%?:OX8TK[7_ ,)G_P (
MQ_:G]K_\)'X/\6>?Y'_"*:=]@^Q_8/*\Z]^T?:O,@^S?QA^$?VEOVC?A_P"'
MM/\ "/@/X_\ QL\$^%-)^U_V5X8\(_%7QUX;\/:9]OOKG4[[^S]%T;7K+3;+
M[;J5[>:A=_9K:/[3?7=S=S;YYY9'Z3_ALC]KS_HZG]I#_P /C\3O_FHKZ#!>
M-?"[X2RKA3.N%,;FF$P>3Y1EN+ISQ.&6'Q4\JH82,:J@[34/K&%A7IINZ<8W
MV9]YD_TRO#.7A5PQX7<8^%V<\397E'"?"?#N;8>MF&7++\SK<,8+*Z=/$JD^
M2K&D\?EE'&T(2FI1<*:G>TD?TR>$?^"'/[%_AOQ#I^M:SJGQL^(&FV7VO[3X
M1\7>.= LO#VK?:+&YM(?[0N? ?@GP3XKC^P3SQ:G:?V5XGTS??65M'??;=->
M\T^[_3+1M*^"_P"S%\)=*T.QE\$_!GX-_#G3;'2K2?6=9L/#/A3P_:WNI16E
MO+JOB'Q#?0Q2:EKNOZHCWVLZYJ5QK'B7Q+J\M]J5]J.N:K-<7/\ #3_PV1^U
MY_T=3^TA_P"'Q^)W_P U%> ZSK.L>(]8U7Q#XAU74M=U_7=2OM9US7-9OKK5
M-8UG6-4NI;[4M5U74KV6>]U'4M1O9YKN^OKN::ZN[J:6XN)9)9'<XX'QHX.X
M:A6GPEX=8? XS$0J4ZF(J8K#X>IRR4'",Z]+"8K%5\.JM.G4EA/;X>DW%SC*
M-23F<N2_3$\(_#JABZOA7]'W 9)FV/I5Z&(Q]?,\!E]94YPHRI4ZV-PN59EF
M>.P$<3AZ%:IE7US X9SINM3J4L14E5/VP_X*I?\ !2_PI^TGH^G? +]GZ]U*
M^^$=IJ6C^*/&WQ!EC\2^&9/B'K%G:RW&E>$['PUJ*Z->GP3X<O;N'5=5/B_1
MFNM:\<Z/HU]HVFZ3I_A#3]>\8?A[117XAQ1Q/FW%^<8C.\YJ4YXNNH4XTZ$'
M2PV%P]._LL+AJ<IU)0HTE*5N>I4JSE*=2K4J59SG+^+?$OQ*XI\6.+<?QGQ=
MB:%;-,;&E0I8?!498;+LMP&'YEA<MRW#SJUZE'!X93FX>VKXC$U:E2KB,5B<
M1B:U:M4****^>/@0HK_2 HK^J/\ B6?_ *K;_P UO_\ #Q_IY_Q3A_ZO+_YS
MS_\ 'D_S?Z*_T@**/^)9_P#JMO\ S6__ ,/!_P 4X?\ J\O_ )SS_P#'D_S?
MZ*_T@**/^)9_^JV_\UO_ /#P?\4X?^KR_P#G//\ \>3_ #?Z*_T@**/^)9_^
MJV_\UO\ _#P?\4X?^KR_^<\__'D_S?Z*_P!("BC_ (EG_P"JV_\ -;__  \'
M_%.'_J\O_G//_P >3_-_HK_2 HH_XEG_ .JV_P#-;_\ P\'_ !3A_P"KR_\
(G//_ ,>3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %P AX# 2(  A$! Q$!_\0
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MT?\ "1Z)_P!!C3O_  )3_&C_ (1O0_\ H#:9_P" J?X4?\(WH?\ T!M,_P#
M5/\ "@ _X2/1/^@QIW_@2G^-'_"1Z)_T&-._\"4_QH_X1O0_^@-IG_@*G^%'
M_"-Z'_T!M,_\!4_PH /^$CT3_H,:=_X$I_C1_P )'HG_ $&-._\  E/\:/\
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MB?\ 08T[_P "4_QH_P"$;T/_ * VF?\ @*G^%'_"-Z'_ - ;3/\ P%3_  H
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MPV/E4J2 .@/9><]5X=LKF"74KN]1(I[ZX$QB5MPC41H@!/<X3)QZT 2>+/\
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MRGPTODO/"\,:(RFU8PMGN>#D?]]5U=<M2#IS<7T.JG-5(J2ZA1114%A1110
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M:?\ 0?T7_P %+_\ Q^C^S_&G_0?T7_P4O_\ 'Z .LHKD_P"S_&G_ $']%_\
M!2__ ,?H_L_QI_T']%_\%+__ !^@#K**Y/\ L_QI_P!!_1?_  4O_P#'Z/[/
M\:?]!_1?_!2__P ?H ZRBN3_ +/\:?\ 0?T7_P %+_\ Q^C[!XS_ .@_HO\
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M/T?V?XT_Z#^B_P#@I?\ ^/T =917)_V?XT_Z#^B_^"E__C]']G^-/^@_HO\
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M/_D5=&_Z\H?_ $ 4>+/^15UG_KRF_P#0#1X3_P"15T;_ *\H?_0!0!JT444
M%%%% !1110 4444 %%%% !1110 445E>(M8CT6T@GF0N)9TAP#C&[J?P -.,
M7)V0I245=FK1535;V/3=-N+R;)CA0N0.I]JYKP+XD.MW.H+.^V0L)88CU6/
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M5)%6TB <7%N PV#GF2@#OJ*Y/_A)M;_Z$W5?_ BW_P#CE'_"3:W_ -";JO\
MX$6__P <H ZRBN3_ .$FUO\ Z$W5?_ BW_\ CE'_  DVM_\ 0FZK_P"!%O\
M_'* .LHKD_\ A)M;_P"A-U7_ ,"+?_XY1_PDVM_]";JO_@1;_P#QR@#K**Y/
M_A)M;_Z$W5?_  (M_P#XY3/^$KU?SC%_PB&I^:%W%/M-MG'K_K* .OHKD_\
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MCC(XK*K45:#<5:S_  ?_  36E3=&:4G>_P"?_#'I%%<G_P )-K?_ $)NJ_\
M@1;_ /QRC_A)M;_Z$W5?_ BW_P#CE<9V'645R?\ PDVM_P#0FZK_ .!%O_\
M'*/^$FUO_H3=5_\  BW_ /CE '645R?_  DVM_\ 0FZK_P"!%O\ _'*/^$FU
MO_H3=5_\"+?_ ..4 =917)-XHUE<;O!VJ#)P,W-MR?\ OY2_\)-K?_0FZK_X
M$6__ ,<H ZRBN3_X2;6_^A-U7_P(M_\ XY1_PDVM_P#0FZK_ .!%O_\ '* .
MLHKD_P#A)M;_ .A-U7_P(M__ (Y1_P )-K?_ $)NJ_\ @1;_ /QR@#K*R/%\
M_P!G\,:G)C/[AEQ_O#']:RO^$FUO_H3=5_\  BW_ /CE87B+Q+J6IVLFG?\
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M_P#A)=;_ .A-U7_P(M__ (Y7)>+4UG5=234I?#]]:QPV[1LCR1L< ,=V58@
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MYQC\:RM*N;JR\:W$UOX9N_,%N M@)8M\0^7YMQ;;V['/S5I0Y52E=:ZO[O\
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MYHDP,+"W^S12+ME[%L_P^N.:KZ;-XKLKAXO$6H:$[W,;1V8MXY%_? 9&[/\
M#U]^E:WA/71KT-[.BA8HYS''Q@E=JG)]\DUSGQ"9)]4CW,Y_L^W%UA/X6,T8
MR?\ @.?RIT\*_:>SDWH*KF-Z;G&$=;=%T[=C4T2'QE%]K.N7FAR@PD6_V>.1
M-LO8MG^'Z<TNAP>,XS=_VU>:),#"PM_LT4B[9>Q;/\/KCFL/QAXF^V^$K6*,
M&.^O564QID[8P2<Y^JUZ';2K/;12QG*2(&4^H(S4SPTJ<5*3?4:S%5922A'6
MW1?AV\SF-#@\9QF[_MN[T28&%A;_ &:*1=LO8MG^'UQS1HL/C*+[6=<O-#E4
MPM]G^SQR+ME[%L_P^N*V=+U>+4;S48(D(^QR^4S$\,<<XJEXLU."/PAJ%U"Z
MRQO$T2LC=2QV=?8G]*F-!\RCK_PY4\?>,I<L=?)=.W;S.'U:W\93WUFNI:II
M#R)%-=6OV*-P/,1006SU!S@?C6GX UGQ-K%O=-J%_HLLGDL((HHW1UE&,,X/
M5>><5:\%^'KW2->N#?$S0K;A8)3R%!/W1Z' K!\0V<NG^/+BXT\_9UB6*X(3
MY0P+HA'XDYKL6'IR_=*3=EHSEGF%17J.G%<S5U;:W;MY]SK=#@\9QF[_ +;N
M]$F!A86_V:*1=LO8MG^'UQS1H<'C.,W?]MW>B3 PL+?[-%(NV7L6S_#ZXYKK
M!17 J=NK.V6+<K^Y'7R7X=CD]#@\9QF[_MN[T28&%A;_ &:*1=LO8MG^'UQS
M1H<'C.,W?]MW>B3 PL+?[-%(NV7L6S_#ZXYKK**%3MU8Y8MRYO<CKY+\.QR>
MAP>,XS=_VW=Z),#"PM_LT4B[9>Q;/\/KCFO.M-N_$LOC:>#4I["2Z>Y4(88W
M6/S8P54D'^'GGO7N-><V<&?&>GR ?\Q"_P _@!_C75A::5VV]$^IS8K&2EHH
M1U:^RM/3MYFUH<'C.,W?]MW>B39A(M_LT4B[9>Q;/\/KCFC0X/&<9N_[;N]$
MF!A86_V:*1=LO8MG^'UQS7645RJGMJSIEBW+F]R.ODOP[')Z'!XSC-W_ &W=
MZ),#"PM_LT4B[9>Q;/\ #ZXYHT.#QG&;O^V[O1)@86%O]FBD7;+V+9_A]<<U
MUE%"IVZL)8MRYO<CKY+\.QR>AP>,XS=_VW=Z),#"PM_LT4B[9>Q;/\/KCFC0
MX/&<9N_[;N]$F!A86_V:*1=LO8MG^'UQS7644*G;JPEBW+F]R.ODOP[')Z'!
MXSC-W_;5YHDP,+"W^S12+B7L6S_#ZXYJ/3+/QC)!J$.O7>BS1RVSI!]FCD4K
M(1@%L_PUV%!&::A:VK%+%N7->$=?)?AV/#OAWI&NVNMVEU=O8DW$%Q]D(1@!
M(JX!;_9Y[5WUEIOBR[M;^V\33Z'=V\L!$*6\<B?O005+9_A^G-=9#9V\"Q+%
M#&BQ B/"_=SUQ4]:U).<E*[T\S*-:T91Y(^]VBOP.3T.#QG']K_MJ[T24& B
MW^S12+ME[%L_P^N.:\^\*^'?$VKZE->7=WIP%C.ZQ;5<*9@^_I_=)8U[;4<4
M4<((B14#,6(48R3U-*DW37NMW]2JM?VK=X1U_NK\.WF<#I\/BVW\30MKMUH\
M\\]G/%:FVC=51QM;+YZCZ5K:'!XSC-W_ &W=Z),#"1;_ &:*1=LO8MG^'UQS
M6AJO_(U:%_N7'_H*UN4I4[*.KV[^;!8MR<_<CK;HNRV.3T.#QG&;O^V[O1)@
M86%O]FBD7;+V+9_A]<<T:'!XSC-W_;=WHDP,+"W^S12+ME[%L_P^N.:ZRBLU
M3MU9I+%N7-[D=?)?AV.3T.#QG&;O^V[O1)@86%O]FBD7;+V+9_A]<<T:'!XS
MC-W_ &W=Z),#"PM_LT4B[9>Q;/\ #ZXYKK**%3MU82Q;ES>Y'7R7X=CD]#@\
M9QF[_MN[T28&%A;_ &:*1=LO8MG^'UQS1H<'C.,W?]MW>B3 PL+?[-%(NV7L
M6S_#ZXYKK**%3MU82Q;ES>Y'7R7X=CD='C\8P+>OKMYHDJ"!C ;>.1=LG8MG
M^'UQS7#>$O$'B'3=%@AU"73YK6Z$MO:F-65HI,CECW7+]N:]4\3OL\.:HWI:
MR_\ H)KQ[5T)TV*R@0[K.2>9L=EW*O\ 2N["8:-16DWOW\F<6,S&<6^6$=5_
M*OP[>9+I&C>)_$EY:M>7NF2?9;*(QR(K@C.XKOSU.0<XKO+'3_&%S9:G:^(+
MS198[BU>*$VL4BE9", MG^'FJ7PGT^:T357GR&\U8-I[%02?_0A7H%9XF/+-
M04FU'8TH8KVD)3=.*<M]%T[=O,\VET[Q98^%-1@UFZT>:VM[1?LPM8W5@Z%2
M-V>HPM0^#-:\3:MH>M7&K7FERQQ6\HC6*)T=),$J6[%<9]^*[[Q)$9O#^I1(
MI9GMI%  R2=IQ7 );?V7X<UZTMF,,DBVL8!/)9T7</QRU.C1C.%FW>_?O8FO
MC91F[0C9K^5=+[=O,XOPA<^(KS4+'3'N;,QC A4*VT,KF0%AZ9ST[5Z=H.E>
M*X=2OK[6;C0Y;F2U,,+VT<BX<'*[L_P^N.:O6/@^PL-7L;^R7RF@WF1<D[RR
MX'TQDUU I8APDU[-NWFRJ->=I>TA&[MM%:6[=O,\X5O%5EXJ\,_\)/<:3<P7
M-[);1"RC=&1_LL\F3NZC$1'XUZ.*Y7QE_P C%X$_[#4G_INO*ZJL$K)*Y56I
M[2;G9*_960445#>-(EI,T"[I51B@QG+8XIF9-17#VGB"_%@(9KD-JTTEO%Y,
MUH8#!YAP6*Y.X<-CW7%;_AV]NKB34K2_:.2XL;CR#+&NT2 QI(#CL</C'M0!
M)XL_Y%76?^O*;_T T>$_^15T;_KRA_\ 0!67\0/$&E:3H&HVVI7T-M//93>4
MCGE_D(X_&LWPSX\\+P^&])CDUNS5TM(E8%CP0@SVH [NBN7_ .%@>%?^@Y9_
M]]'_  H_X6!X5_Z#EG_WT?\ "@#J**Y?_A8'A7_H.6?_ 'T?\*/^%@>%?^@Y
M9_\ ?1_PH ZBLOQ/>)8^'[^=RHVPL%R>K$8 _.LO_A/_  K_ -!RS_[Z/^%<
MYXR\4^']9@LK.'6+<V;3@W,B'[B@'!/'K6E**E-)[&=5M0=CL(-$@N=#TFTO
MU+_8UB<#/!=5QS[<FJ/Q%LYKGPL\%I"SN)(P$0=!G% \?^%0,?VY9_\ ?1_P
MI?\ A/\ PK_T'+/_ +Z/^%$:LHS4NSN*5)2@X]S@+>">RTDZW*[/J&G7ZVH5
MC\NQ% V_TKH_ F@M<B]O;Z*.2PU&+(0GKER<'Z8%7%\3^!Q!/"=5L'BFF-PZ
MLQ(+DYSTJU:>-O!]G;1V]MK-C'#&NU$#' %=-3%\T6DM?T.>GA.62;V_4YQ=
M6@ATG4?# !$_VYK:!57@QM*._KRWZ5Z5/;0W"1K-&CK&RN@(^ZPZ$?2O,]:U
MKPI+XDT_5+'4;9Y!<*]TZL<*H'#'CU KJ_\ A/\ PK_T'+/_ +Z/^%9UY1DH
MRCUU^9I0BTY1ETT^1U%%<O\ \+ \*_\ 0<L_^^C_ (4?\+ \*_\ 0<L_^^C_
M (5S'2=117+_ /"P/"O_ $'+/_OH_P"%'_"P/"O_ $'+/_OH_P"% '45Q/CN
MP2_\0>'H903%,\L4@!YQA3_B:O?\)_X5_P"@Y9_]]'_"LO4O%_AFZU;2;I-=
ML=MI)(S@L<D,A7CCUQ6M&?)/F]?R,JT.>/+Z?F:'@^QAT2XUNRB9C!;R1L&;
MKS&":@\(6,VJ6NI:CK409=3V[(V.<0C) ^G/Z5F1>+]#_MC6S%J5NUO>0IY<
M@)PT@0J5'OC%7]!\;^&K30M/M[G6+6.>&WCCD1B058* 0>/6M:DI).75VU^1
ME3BFU'HK_F8'@O2I-8:>\D5C%:6QM+?G #E"&&/3YR?QJ;_A))AX5M]%BF==
M>:3[(5Q@I\Y4#/0'&!4_@SQ5X>TFQO([S5;:"2:[DF".2/E. "..A JE8:MX
M.;Q+J=_>ZE:?\?*3VLFX@$XR2..?F_45O*K%SESK16L81I24(\F[W-3X<?:;
M*SUG[:KBZPMP1)U((;!/U(-8.A%]4TVT\-3EU#W*3[U&/W31LY'X&M#5?&>E
MGQ!>RZ=>)=6]QIWDLT7.V4%]N?\ />H='UW0+/Q'9WLVK6HMXM.2W+9.$E4*
M-IXZXW?E5<^CJ-;ZKU1/)JJ:>VC]&>J@84"N=\;6L(T6]O?+'VA4C!?OL60-
MC\ZB_P"$_P#"O_0<L_\ OH_X5E^*/&GAR_\ #]]:V>KVLUQ+&52-6.6/ITK@
MI/WUZG?57N/T.\%%<LOC_P *@#_B>6?3^\?\*7_A8'A7_H.6?_?1_P *S-$=
M117+_P#"P/"O_0<L_P#OH_X4?\)_X5_Z#EG_ -]'_"@#J*YWPO!%*U_.R*TD
M>H7&Q_3+<X_*N1\9>/X9HOLWA^\AEAD4;[J-CE&R?E''4\?G6EX5\6>&-(T*
MUM)];LQ.H)ERQSN)).>.O-=#IN%+F?4YU-3J\J6QWU%<O_PL#PK_ -!RS_[Z
M/^%'_"P/"O\ T'+/_OH_X5SG0=117+_\+ \*_P#0<L_^^C_A1_PL#PK_ -!R
MS_[Z/^% '445R_\ PL#PK_T'+/\ [Z/^%'_"P/"O_0<L_P#OH_X4 =117+_\
M+ \*_P#0<L_^^C_A1_PL#PK_ -!RS_[Z/^% '445R_\ PL#PK_T'+/\ [Z/^
M%'_"P/"O_0<L_P#OH_X4 =117+_\+ \*_P#0<L_^^C_A1_PG_A7_ *#EG_WT
M?\* +>J_\C5H7^Y<?^@K6[7!7_C/P[-K^E746KVK6]NLPE<,<)N"A<\=\&M7
M_A8'A7_H.6?_ 'T?\*TG\,?3]69PWEZ_HCJ**Y?_ (6!X5_Z#EG_ -]'_"C_
M (6!X5_Z#EG_ -]'_"LS0Z@UQL/B8VWCC4=,O' M,*8W8X",(P2/Q^:K7_"P
M/"O_ $'+/_OH_P"%><^*;_2-0?4;FSU&&2ZFNU:.,,<RQ!,97CU+?E75A80G
M)QGU_P SFQ4Y0BI1Z'L&B:@FJZ9!>Q(R),NX*W4<X_I5ZO/O"?C'P[IGAZUM
M+W5[6":(N"CL0<;V*G\1@U:UCX@Z.NDW#:9?Q27X3*0X.Y3ZD>W6LY4FZCC%
M=;%QJI4U*7:YN^-#M\*ZH>G[AA7,^&M-CO/$?B2VNDS"%$6.A*NQ;_"CQ%XS
MT#4/#\EM'J=L;N3RRT /((=2P_  _E6HGCKPBCLZZS8*[XW,#@MCIGBJC-TZ
M;7?_ (!$H*I44NW_  3J8XUCSL4#/7 ZT^N7_P"%@>%?^@Y9_P#?1_PH_P"%
M@>%?^@Y9_P#?1_PKG.DZBO/=1EAG\</ISC=(]];S[2.-J0DG]<5M?\)_X5_Z
M#EG_ -]'_"N)?7M(?XD#6#J5LNFJ,B=F.UCY>W ]\_R-=.&M>3?9G-B;^ZEW
M1Z]17+_\)_X5_P"@Y9_]]'_"C_A8'A7_ *#EG_WT?\*YCI&^,O\ D8O G_8:
MD_\ 3=>5U5>>:SXHT76_%G@>VTK4K>ZG75Y9&2,Y(4:?>#/YD?G7H= !3)H_
M-A>/<R;E*[E.",]Q[T^B@# ;PM:2+,;BYO9[B3R\7,DH,D?EL63:0 !AB3T[
MUHZ3ID.F0RK"\LKS2&6665MSR,0!DGZ #Z"KU% &/XNC1O"^L%E5B+*;!(SC
MY#2>%((CX6T<F*/_ (\H?X1_<%2>+/\ D5=9_P"O*;_T US?A_Q;96=CI.ES
MI()Q!:1*>S;XU.?H.,U482GI%$RG&&LF=I]GA_YY1_\ ?(H^SP_\\H_^^14M
M%241?9X?^>4?_?(H^SP_\\H_^^14M% $7V>'_GE'_P!\BL35(8AXJT,>6F#'
M<$C:/1*Z"L+4_F\6Z*!_##<,?R05I3W^3_(SJ;?-?F;'V>'_ )Y1_P#?(H^S
MP_\ /*/_ +Y%2BBLS0B^SP_\\H_^^11]GA_YY1_]\BI:* *\EC;2/&[V\1:,
M[D)4<'&/Y&G_ &>'_GE'_P!\BI:* (OL\/\ SRC_ .^11]GA_P">4?\ WR*E
MHH B^SP_\\H_^^11]GA_YY1_]\BI:* (OL\/_/*/_OD4?9X?^>4?_?(J6B@#
M@?'"QPZE.FU%%U8I$, #_ENH;\</^E=P+>$  11_]\BN2\9VXG\4^&5/1Y7#
M#U"E&Q^E=F*WJO\ =P_KR_0PI)\\_P"O/]2G9Z;9VD;);V\:*SER-N>3R:G^
MSP_\\H_^^14M%87;W-DK:(X_QSX8EUQM/^R>5&L,A$HQ@E6*Y(^@!KJ(;2"*
M%(TB3:BA1E1T%6**N524HJ#V1,:<8R<UNR+[/#_SRC_[Y%8OC2",>%=3*1(&
M\DX(45OU6U0!M-N@P!'E-P?H:4':28YJ\6BEX<2*;P_ILC11Y:VC8_*/[HK1
M^SP_\\H_^^15#PK_ ,BSI/\ UZ1?^@"I+_41:ZCIUILW&[=USG[NU"V?TIR3
M<VEYBB[03?D6_L\/_/*/_OD4?9X?^>4?_?(J44&H+/-K%_[1^*<S&+=;6P>%
M1L^52JX/ZDG\:]$%O#_SRC_[Y%<]X)1E.N.PPLFISLI]1D#^AKIJZ,1).22Z
M)(PP\6HMOJ[D7V>'_GE'_P!\BC[/#_SRC_[Y%2T5SFY%]GA_YY1_]\BC[/#_
M ,\H_P#OD5+10!%]GA_YY1_]\BC[/#_SRC_[Y%2T4 1?9X?^>4?_ 'R*/L\/
M_/*/_OD5+10!%]GA_P">4?\ WR*/L\/_ #RC_P"^14M% $7V>'_GE'_WR*/L
M\/\ SRC_ .^14M!H Y[5X8AXDT'$:8)G!&T<_)_]:MS[/#_SRC_[Y%<YXNNC
M9:QX=G";\W1B(SC[Z[<_K73BM)I\L7_6[,H/WI+^MC)\2R#3]!O;NWCA$L41
M9=R C-4_!5RVIZ&DU]'&;M9)$E'E@;2&.!CV!%.\=QFX\/M:!BGVJ>&#<.VZ
M1:K^'+V"#7-6T]F(FDNGD08X($<>?QYK2,4Z+TU(E)JLM=#I#;P_\\H_^^17
M*^&[&WUC3=7>ZB1[6]O)&CP,'8,*/I]VNHOKJ&RM7N+J18H4QN=CP,G _4UD
M^" !X5T_']PG_P >-1%N,')=T7*TIJ+\SR/6;RYA:^T\J52.[8H0/N[6DR/_
M !\?D*U/#<$\>L6.BW>WY;B61T." WD_*<_G7I\&@:=%+>OY D-XY>42?,,G
MKCTS65:>'%3QQ=ZJ\9\ORU:)L_QD%6_0?K7?]<A*+C:VGXG#]4G&2E>^OX'(
M>=/J>BZ%I<*JUU%=&*58U&=L9 !/M@_I7JHMX?\ GE'_ -\BN?T_PQ%:^++S
M6 5"R >5&G&TD8<GZ]:Z6N/$5(SLH;?JSKP].4;N7]6(OL\/_/*/_OD4?9X?
M^>4?_?(J6BN<Z"+[/#_SRC_[Y%9UOH=K#K=UJ04&2XC6,H5&%QW'UX_*M:BF
MI-;"<4]R+[/#_P \H_\ OD4?9X?^>4?_ 'R*EHI#.2\7Q1IXD\"%$53_ &S(
M,@8_YAUY76UROC+_ )&+P)_V&I/_ $W7E=50 4444 %%<U'XNMIEOC#;S.()
M8H8<8_TAI#A2OL2#R>W/2M31=3&I1W :![>XMI3#/"Y!*-@,.1P0593GWH 9
MXKP?"^K[C@?8YLG_ ( :\6\.V>M7^DWVM:C8P)!:VJ+;LLN=[Q>6 I';Y5QF
MO;M=DCBT:^:8C8()"V?3:<UYWX5UVQUCP5=:/;V]] T5DTK2O;D*_.?E]2<]
M.]:4ZBIM/FL_TZFBI3JTY)4E)+J[Z/I:S6_FF;O@_P 1^(]:MKJXNM'L8X5A
M8P-!=[]\HQA&X^7KUJUH>I>+9S=_VSH-G:A(2\'E7>_S).RGC@'UKF/A7XAM
M8;/5K+[/? VP-V6D@*[AL4%0#WR.!WKI-!\>6.L_:_*L=2A^S0M.WG6Y7<!V
M7U;VKGGR1G:$VUT\_P #NY*SC)SPZ3TOOIZ>]U^8_0]3\6SF[_MG0;*U"0EX
M/*N]_F2=D/' /K1H>I>+)S=_VSH-G:A(6>#R;O?YDG93QP#ZURNI?$M-8L)8
MM @OK:[C?<3-#MW*H)('OP.*UM&^)FFZEI]U(MO=QSVUHTY\Z(HLK*.54]SD
M]*:AI%\V_P#78*G/>HG02M;OIZ>]UZ[C]*\6Z[]IU6WUS2;&UFL[1KA(X;O>
MSL!D+TXR.]97@OQ'KWB/Q!<7MYI-O +:QD^S)'-D.Y9>"3ZE3SVK$MKD>+(]
M1NT@O;/4UWW,I>%E5H<!?+4]S@9 [Y-=1\/?$.EQ:=<V=I::F/LL3W+R7%ML
M,@S]U?4^@K5^QA!.-1N7]7Z&,H8F4YJ>&BDK=].UO>Z];W-G0]2\6SF[_MG0
M;.UV0EX/*N]_F2#HIXX!]:-#U+Q;.;O^V=!L[4)"7@\J[W^9)V4\< ^M,T'Q
MW8ZS]K$-CJ4/V:!IV\ZW*[@.R^K>U&@^.['6?M8AL=2A^S0-.WG6Y7<!V7U;
MVKF36GO?U]QTU*=3W[T$MN^GI[W7YC]#U+Q;.;O^V=!L[4)"7@\J[W^9)V4\
M< ^M&AZEXMG-W_;.@V=J$A+P>5=[_,D[*>. ?6F:#X[L=9^UB&QU*'[- T[>
M=;E=P'9?5O:C0?'=CK/VL0V.I0_9H&G;SK<KN [+ZM[4)K3WOZ^X*E.I[]Z"
M6W?3T][K\Q^AZEXMG-W_ &SH-G:A(2\'E7>_S).RGC@'UHT/4O%LYN_[9T&S
MM0D)>#RKO?YDG93QP#ZTS0?'=CK/VL0V.I0_9H&G;SK<KN [+ZM[4:#X[L=9
M^UB&QU*'[- T[>=;E=P'9?5O:A-:>]_7W!4IU/?O02V[Z>GO=?F/T/4O%LYN
M_P"V=!L[4)"7@\J[W^9)V4\< ^M&AZEXMG-W_;.@V=J$A+P>5=[_ #).RGC@
M'UIF@^.['6?M8AL=2A^S0-.WG6Y7<!V7U;VHT'QW8ZS]K$-CJ4/V:!IV\ZW*
M[@.R^K>U":T][^ON"I3J>_>@EMWT]/>Z_,?H>I>+9S=_VSH-G:A(2\'E7>_S
M).RGC@'UHT/4O%LYN_[9T&SM0D)>#RKO?YDG93QP#ZTS0?'=CK/VL0V.I0_9
MH&G;SK<KN [+ZM[4:#X[L=9^UB&QU*'[- T[>=;E=P'9?5O:A-:>]_7W!4IU
M/?O02V[Z>GO=?F/T/4O%LYN_[9T&SM0D)>#RKO?YDG93QP#ZT:'J7BV<W?\
M;.@V=J$A+0>5=[_,D[*>. ?6F:#X[L=9^UB&QU*'[- T[>=;E=P'9?5O:C0?
M'=CK/VL0V.I0_9H&G;SK<KN [+ZM[4)K3WOZ^X*E.I[]Z"6W?3T][K\RKI[>
M)]2ODN=<T*TM7L8WEM?)NP_FR%<;&XX!SU]JNZ'J7BV<W?\ ;.@V=KLA+P>3
M=[_,D[*>. ?6F:#X[L=9^UB&QU*'[- T[>=;E=P'9?5O:C0?'=CK/VL0V.I0
M_9H&G;SK<KN [+ZM[4U).RYW_7R%.E47._8);7WT]/>Z_,?H>I>+9S=_VSH-
MG:A(2\'E7>_S).RGC@'UHT/4O%LYN_[9T&SM0D)>#RKO?YDG93QP#ZTS0?'=
MCK/VL0V.I0_9H&G;SK<KN [+ZM[4:#X[L=9^UB&QU*'[- T[>=;E=P'9?5O:
MDFM/>_K[AU*=3W[T$MN^GI[W7YC]#U+Q;.;O^V=!L[4)"7@\J[W^9)V4\< ^
MM&AZEXMG-W_;.@V=J$A+P>5=[_,D[*>. ?6F:#X[L=9^UB&QU*'[- T[>=;E
M=P'9?5O:C0?'=CK/VL0V.I0_9H&G;SK<KN [+ZM[4)K3WOZ^X*E.I[]Z"6W?
M3T][K\Q^AZEXMG-W_;.@V=J$A+P>5=[_ #).RGC@'UJ'3]0\5W5KJ2ZWH5G:
M(MJ[0F&[\S?)CA3QP#ZT_0?'=CK/VL0V.I0_9H&G;SK<KN [+ZM[4S2/'-CK
MD-^D-CJ4!@MVF;SK<KN [+ZM[4XN-U[W]?<*K3J6G>@EMWT]/>Z_,K>!=1\3
M2Z)&M_HMI#;QV*FT>.ZW&9@HVJPQ\N?7M6<=1\4S^*-&.M:)9VCQI<-;+#=[
M_-?RC\IXX[<^]7/ /C.SO=#2V6SU"-[&S$CM) 0'"CD*>Y]!6%J'Q"M-2\3:
M--:65_']C+M(D\!4L'PORCN<9P*WHVE5LIM_%\]'Y&->%2-.7-AXJW+??35;
M>]_F=CH>I^+9S=_VQH-G:A(6>#RKO?YDG93QP#ZTFBZIXKE%XVMZ'96:QP,\
M)CO ^^0=%/' /K6?;?$W39\_\2_5(@" 3+;E>N>GJ>.E5[[QQ9:[X>UN*WM-
M0MFBM&<FX@*!NVT'N>>E902;C[SU_KL:58U(JI^X2M;OIZ>]U^8_X>:EXBN;
M"_DNM'M(X6:>:!X[K=YDQ<_(?09SS[5K:'J7BV<W?]LZ#9VH2$O!Y5WO\R3L
MIXX!]:P/A;XLM)?#K6@M+Y'LXI+AV:$A7&X\*>[<]*W-!\=V.L_:Q#8ZE#]F
M@:=O.MRNX#LOJWM14<>?2;>_S_ /9U5"7-AXK:^^GI[W7YC]#U+Q;.;O^V=!
ML[4)"7@\J[W^9)V4\< ^M&AZEXMG-W_;.@V=J$A+P>5=[_,D[*>. ?6F:#X[
ML=9^UB&QU*'[- T[>=;E=P'9?5O:C0?'=CK/VL0V.I0_9H&G;SK<KN [+ZM[
M5":T][^ON+J4ZGOWH);=]/3WNOS'Z'J7BV<W?]LZ#9VH2$O!Y5WO\R3LIXX!
M]:-#U+Q;.;O^V=!L[4)"7@\J[W^9)V4\< ^M,T'QW8ZS]K$-CJ4/V:!IV\ZW
M*[@.R^K>U&@^.['6?M8AL=2A^S0-.WG6Y7<!V7U;VH36GO?U]P5*=3W[T$MN
M^GI[W7YC]#U+Q;.;O^V=!L[4)"7@\J[W^9)V4\< ^M&AZEXMG-W_ &SH-G:A
M(2\'E7>_S).RGC@'UIF@^.['6?M8AL=2A^S0-.WG6Y7<!V7U;VHT'QW8ZS]K
M$-CJ4/V:!IV\ZW*[@.R^K>U":T][^ON"I3J>_>@EMWT]/>Z_,?H>I>+9S=_V
MSH-G:A(2\'E7>_S).RGC@'UHT/4O%LYN_P"V=!L[4)"7@\J[W^9)V4\< ^M,
MT'QW8ZS]K$-CJ4/V:!IV\ZW*[@.R^K>U&@^.['6?M8AL=2A^S0-.WG6Y7<!V
M7U;VH36GO?U]P5*=3W[T$MN^GI[W7YC]#U+Q;.;O^V=!L[4)"7@\J[W^9)V4
M\< ^M&AZEXMG-W_;.@V=J$A+P>5=[_,D[*>. ?6F:#X[L=9^UB&QU*'[- T[
M>=;E=P'9?5O:C0?'=CK/VL0V.I0_9H&G;SK<KN [+ZM[4)K3WOZ^X*E.I[]Z
M"6W?3T][K\Q^AZEXMG-W_;.@V=J$A+P>5=[_ #).RGC@'UHT/4_%LYN_[9T&
MSM=D):#RKO?YDG93QP#ZTS0?'=CK/VL0V.I0_9H&G;SK<KN [+ZM[4:#X[L=
M9^UB&QU*'[- T[>=;E=P'9?5O:A..GO?U]P5*=1<]Z"6W?3T][K\SE/%UWXM
MN=(-UK&BVEA]BD6:&6"[\PE\X (QZD<UJ?#_ ,4^(M>757O=,M56)"\&RXR3
M)@80CL#@G=5RV\6:3XLL=1LYM/U..&* SN)8"FX*0<+ZMG'%<OX3\2:987FM
MO9VNH6MI%8))^^@*LS A<X]26_G733E3G24'-W6VVNWD<U:E7A4G/ZO%+2^^
MGI[W7YD>@Z_XFU72+:"]TZV81WL:Q2"XRTDBG>$([# ^]45S<>*;#Q@FL:GH
MMO:%W4(D=QO1V9=I&>V0.O;BJOP_UY+CQ!"A@ND@M86NV5H2"[+$1QZD@\>M
M=E<>+;3Q5HNK6MGI^H13PVS3I]H@*9*X("D_Q>@K9U(4ZD5&=T[]NOR,Y4*T
MX5'+#I-6[Z6VM[SW\[F3XGU?Q1>6<>E:YHEI9?;758&@N_,W.&7Y3QQU'-=)
MX/G\56VGM::KH=G;I:VFVW:*[#F610 %/'&?6O.=$\1W'B?7K>>X2X\VUD^U
MR Q%04C"DA1_>(7IW->F:#X[L=9-YY5CJ4/V:!IV\ZW*[@.R^K>U8U>6$(04
M[[O^M#2-.K*=6<L.H[=]/_)GO\Q^AZEXMG-W_;.@V5J$A+P>5=[_ #)!T4\<
M ^M&AZEXMG-W_;.@V=J$A+P>5=[_ #)!T4\< ^M,T'QW8ZS]K$-CJ4/V:!IV
M\ZW*[@.R^K>U&@^.['6?M8AL=2A^S0-.WG6Y7<!V7U;VKF36GO?U]QTU*=3W
M[T$MN^GI[W7YC]#U+Q;.;O\ MG0;.U"0EX/*N]_F2=E/' /K1H>I>+9S=_VS
MH-G:A(2\'E7>_P R3LIXX!]:9H/CNQUG[6(;'4H?LT#3MYUN5W =E]6]J-!\
M=V.L_:Q#8ZE#]F@:=O.MRNX#LOJWM0FM/>_K[@J4ZGOWH);=]/3WNOS'Z'J7
MBV<W?]LZ#9VH2$O!Y5WO\R3LIXX!]:-#U+Q;.;O^V=!L[4)"7@\J[W^9)V4\
M< ^M,T'QW8ZS]K$-CJ4/V:!IV\ZW*[@.R^K>U&@^.['6?M8AL=2A^S0-.WG6
MY7<!V7U;VH36GO?U]P5*=3W[T$MN^GI[W7YC]#U+Q;.;O^V=!L[4)"7@\J[W
M^9)V4\< ^M&AZEXMG-W_ &SH-G:A(2\'E7>_S).RGC@'UIF@^.['6?M8AL=2
MA^S0-.WG6Y7<!V7U;VHT'QW8ZS]K$-CJ4/V:!IV\ZW*[@.R^K>U":T][^ON"
MI3J>_>@EMWT]/>Z_,?H>I>+9S=_VSH-G:A(2\'E7>_S).RGC@'UHT/4O%LYN
M_P"V=!L[4)"7@\J[W^9)V4\< ^M,T'QW8ZS]K$-CJ4/V:!IV\ZW*[@.R^K>U
M&@^.['6?M8AL=2A^S0-.WG6Y7<!V7U;VH36GO?U]P5*=3W[T$MN^GI[W7YG/
M7-_XGN_%W@I/$6C6EA -6D,<D%UYI9O[/O.",>F>?:O4*\MF\96GB3Q=X*MK
M6RU"W>+5I)"US 44C[!># /KS7J5:4VN71W./%QE&HU*"@^RO^K?YA4%_;+>
MV4]M(\B)-&T;-&VU@",9![&IZ*LYCBSX.G@GN)K._=F#VTELEP=RJ8CT; Z$
M<#'3-;V@:?/9M?W%[)&]W>S^?((@=BX144#//1!^)-:U% '*_$+P]I>K:!J-
MSJ-H)YX+*;RV+L-OR$]B.]9OAGP'X:F\-Z3))IBL[VD+,?.DY)0?[5=/XL_Y
M%76?^O*;_P! -'A/_D5=&_Z\H?\ T 4 <I:^#O#[^)K^QGTX&%((I8%,CX&2
MP8YW>N/RJMJFD^"++4GTU]/ O0A(S))M#;<@$[N_'YUJ>+M2;0/$^GZB%\Q+
MJ VK*3@*!(K;OR8U0N-)MO$2^)M1MXUN;DR?9[?!X!1%Y'N3_*NR-*,K3GM;
M\=CCE5DKPAO?\-S*T'PA!<:MIIN[0SZ;=6*SL2QP'V@]<\<FJ7ASPS;ZG?7.
MGS I>6\<JRR!B0'#@+['C=TKUO2K;['IEI;?\\84C_( 5S?@_3?*\1>(K[?]
MZZ:$)CIT<G_QX5:Q+:D[[;?U\R'ADG%=]_Z^1+_PK_PP0,Z6O_?Z3_XJE_X5
M_P"&#_S"U_[_ $G_ ,574T5P'><M_P *_P##!ZZ6O_?Z3_XJC_A7_A@]=+7_
M +_2?_%5U-% '+?\*_\ #!ZZ6O\ W^D_^*H_X5_X8/72U_[_ $G_ ,574T4
M<M_PK_PP>NEK_P!_I/\ XJC_ (5_X8/72U_[_2?_ !5=310!RW_"O_#!ZZ6O
M_?Z3_P"*H_X5_P"&#UTM?^_TG_Q5=310!RW_  K_ ,,'KI:_]_I/_BJ/^%?^
M&#UTM?\ O])_\574T4 <M_PK_P ,'KI:_P#?Z3_XJC_A7_A@]=+7_O\ 2?\
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MG34$UYG)_P#"/^(O^AQN?_ &'_"C_A'_ !%_T.-S_P" ,/\ A7645F:')_\
M"/\ B+_H<;G_ , 8?\*/^$?\1?\ 0XW/_@##_A7644 <G_PC_B+_ *'&Y_\
M &'_  H_X1_Q%_T.-S_X P_X5UE% ')_\(_XB_Z'&Y_\ 8?\*/\ A'_$7_0X
MW/\ X P_X5UE% ')_P#"/^(O^AQN?_ &'_"C_A'_ !%_T.-S_P" ,/\ A764
M4 <G_P (_P"(O^AQN?\ P!A_PH_X1_Q%_P!#C<_^ ,/^%=910!R?_"/^(O\
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M )%71O\ KRA_] % &K1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT4 <EYOC?_GWT#_OJ6CS?&__ #[Z!_WU+76T4 <EYOC?_GWT#_OJ6CS?&_\
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MT4 <EYOC?_GWT#_OJ6CS?&__ #[Z!_WU+76T4 <EYOC?_GWT#_OJ6CS?&_\
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MQ!_X!?\ V5=910!R?_";1?\ 0"\0?^ 7_P!E1_PFT7_0"\0?^ 7_ -E7644
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M644 <G_PFT7_ $ O$'_@%_\ 94?\)M%_T O$'_@%_P#95UE% ')_\)M%_P!
M+Q!_X!?_ &5'_";1?] +Q!_X!?\ V5=910!R?_";1?\ 0"\0?^ 7_P!E1_PF
MT7_0"\0?^ 7_ -E7644 <G_PFT7_ $ O$'_@%_\ 94?\)M%_T O$'_@%_P#9
M5UE% ')_\)M%_P! +Q!_X!?_ &5'_";1?] +Q!_X!?\ V5=910!R?_";1?\
M0"\0?^ 7_P!E1_PFT7_0"\0?^ 7_ -E7644 <G_PFT7_ $ O$'_@%_\ 94?\
M)M%_T O$'_@%_P#95UE% ')_\)M%_P! +Q!_X!?_ &5'_";1?] +Q!_X!?\
MV5=910!R?_";1?\ 0"\0?^ 7_P!E1_PFT7_0"\0?^ 7_ -E7644 <G_PFT7_
M $ O$'_@%_\ 94?\)M%_T O$'_@%_P#95UE% ')_\)M%_P! +Q!_X!?_ &5'
M_";1?] +Q!_X!?\ V5=910!R?_";1?\ 0"\0?^ 7_P!E1_PFT7_0"\0?^ 7_
M -E7644 ><ZMXB35_%O@>!--U2U*ZM*^^ZM_+4_\2^\& <GGG]#7HU<KXR_Y
M&+P)_P!AJ3_TW7E=50 4444 %%%% &5XL_Y%76?^O*;_ - -'A/_ )%71O\
MKRA_] %'BS_D5=9_Z\IO_0#1X3_Y%71O^O*'_P! % &K1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% '*^,O^1B\"?\ 8:D_]-UY755ROC+_ )&+P)_V
M&I/_ $W7E=50 4444 9VO:@^G6<;P1K)<331V\2L<+N=@,GV')_"H] U&>]-
M]!>QQQW=E/Y$GEDE&RBNK#/(R'''KFIM:TU=4LUA,KP21RI-%*@!*.C @X/!
MZ=/0TW1M,&G+<L\[W%S=2^=-,X +-M51P.  JJ/PH S_ !SJNGV/AS5(;V_M
M+:66RF\M)IE1G^0C@$\U4\+^)]!C\,Z0CZWI:NMG"&4W<8(.P<=:U_$&B6FM
M:?<V]S! TDL+PI+)$',>X$9'TSFJ^E^%M)LM,M+5]/LI6@A2(R&W4;RJ@9_'
M% $G_"5>'O\ H.Z5_P"!D?\ C1_PE7A[_H.Z5_X&1_XU-_PC^C_] NQ_[\+_
M (4?\(_H_P#T"['_ +\+_A0!#_PE7A[_ *#NE?\ @9'_ (T?\)5X>_Z#NE?^
M!D?^-3?\(_H__0+L?^_"_P"%'_"/Z/\ ] NQ_P"_"_X4 0_\)5X>_P"@[I7_
M (&1_P"-'_"4^'_^@[I7_@9'_C4W_"/Z/_T"['_OPO\ A69X>\&Z7I5E/!+:
M6=RTEW<W(<VZC:)9WD"=_NAPOX=NE %W_A*O#W_0=TK_ ,#(_P#&C_A*O#W_
M $'=*_\  R/_ !J;_A']'_Z!=C_WX7_"C_A']'_Z!=C_ -^%_P * (?^$J\/
M?]!W2O\ P,C_ ,:/^$J\/?\ 0=TK_P #(_\ &IO^$?T?_H%V/_?A?\*/^$?T
M?_H%V/\ WX7_  H A_X2KP]_T'=*_P# R/\ QH_X2GP__P!!W2O_  ,C_P :
MF_X1_1_^@78_]^%_PK+TGP;I=CJ.M7,EI9S+J%TMPB&W4>2!!%%M'KDQENWW
MOQ(!>_X2KP]_T'=*_P# R/\ QH_X2KP]_P!!W2O_  ,C_P :F_X1_1_^@78_
M]^%_PH_X1_1_^@78_P#?A?\ "@"'_A*O#W_0=TK_ ,#(_P#&C_A*O#W_ $'=
M*_\  R/_ !J;_A']'_Z!=C_WX7_"C_A']'_Z!=C_ -^%_P * (?^$J\/?]!W
M2O\ P,C_ ,:/^$I\/_\ 0=TK_P #(_\ &IO^$?T?_H%V/_?A?\*R_P#A#=+/
MB8:I]DL_*%H;;[/]G7&2X;?G\,=* +W_  E7A[_H.Z5_X&1_XT?\)5X>_P"@
M[I7_ (&1_P"-3?\ "/Z/_P! NQ_[\+_A1_PC^C_] NQ_[\+_ (4 0_\ "5>'
MO^@[I7_@9'_C1_PE7A[_ *#NE?\ @9'_ (U-_P (_H__ $"['_OPO^%'_"/Z
M/_T"['_OPO\ A0!#_P )5X>_Z#NE?^!D?^-'_"4^'_\ H.Z5_P"!D?\ C4W_
M  C^C_\ 0+L?^_"_X5EZAX-TRZUK2KU+2SC2R,I>(6ZXEWIM'TQU[T 7O^$J
M\/?]!W2O_ R/_&C_ (2KP]_T'=*_\#(_\:F_L#1_^@79?]^%_P */^$?T?\
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MTKP;I=EJ>LW+VEG,E_<I.D9MU A"PQQ[1ZY,9;M][\:T_P#A']'_ .@78_\
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M!W2O_ R/_&C_ (2KP]_T'=*_\#(_\:F_X1_1_P#H%V/_ 'X7_"C_ (1_1_\
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M:J_*I)/11G).3F@#4HHHH ***SM5UFPTK9]ON!%N!8?*6PHZL< X49&2>.:
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MI'+J-F\)ECC>5.60Y 5R.H.<\$CG) .]HID,8BACC4DA%"@L<DXI] !1110
M5ER:[91:ZNDRLZ7+H'1F7",3GY W]_"DX]*I:EJL5]=QZ7IVII;732E9'"_-
MM4'<L98%6<' (YP-W<51MY(]7TJYT?4I(KG5 \T:EE*EO+8A)3M^X?N\C'.<
M4 =?15+1K*6PT^*"XNYKR<#,D\IY=NYQT ]A5V@ HHHH *QM;UZ/2I-AM+JZ
M*1F>;[.H/DQ XWMDC/0\#).#Q3->UJ"VWV,-[#;:A)M1'E4E(RQP,G&T'&2
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M^%EU""#R?-+%RJY^Z&/7L">^,FM>BB@ HHJ.YGBMH'FN)$BAC&YW=L!1ZDT
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M)\BMNDR-V&W<;2.!W-=363J?A^QU&Z6YF$\5QM\MI;>=X6=.NUBI&X>QZ=J
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AQPQJ$1%& H'  H ='&L:!8U"J.@ P!3J** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00005.jpg
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %X B0# 2(  A$! Q$!_\0
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M^AZ\2_\ ?G3_ /Y%H_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\
M?G3_ /Y%H_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%
MH_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%H_X1;5O^
MAZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%H_X1;5O^AZ\2_P#?
MG3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%H_X1;5O^AZ\2_P#?G3__ )%H
M ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%H_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X
M1;5O^AZ\2_\ ?G3_ /Y%H_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\
M2_\ ?G3_ /Y%H_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_
M /Y%H_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%H_X1
M;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%H_X1;5O^AZ\2
M_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%H_X1;5O^AZ\2_P#?G3__
M )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%H_X1;5O^AZ\2_P#?G3__ )%H ZNB
MN4_X1;5O^AZ\2_\ ?G3_ /Y%H_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O
M^AZ\2_\ ?G3_ /Y%H_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\
M?G3_ /Y%H_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%
MH_X1;5O^AZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%H_X1;5O^
MAZ\2_P#?G3__ )%H ZNBN4_X1;5O^AZ\2_\ ?G3_ /Y%I? LU_\ :_$UAJ.I
MW.I_V=J:V\,]RD2R;&M+>7!\I$4X:5^=O3% '54444 %%%% !1110 4444 <
MKJ7_ "5/P]_V!=3_ /1]A755RNI?\E3\/?\ 8%U/_P!'V%=50 4444 %%%%
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M4M@&'M\_-%QXQU>WCCDG\.+$DHRC/JEL P]OGYHN@]G+L=Q7*^#?^1B\=_\
M8:C_ /3=9UG7OC75;*V6XN_#JPPLI=7?4[8!AZCY^?PI/A3?3:J?%6ISQ"/[
M;JXE0#H4%G;("#W^X1GU!JDFTY+H0[Q:36YWE%%%("&YM+:Z %U;PS!>@D0-
MC\Z1;*U5HF6VA#1#;&1&,H/0>E3T4 4XM-M4%T&A6074GFS>8 V]L #.>P
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M7_)5/#W_ &!=3_\ 1]A754 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$_\ "7_0P:=_W^%<\Y/DC'YG1"*YY2^1U%<KX-_Y&+QW_P!AJ/\ ]-UG3O\
MA8'A/_H8-._[_"J?PZU"TU35?&UYIUQ'<VLFM)LEC;*MC3[,'!^H(K$V.THH
MHH Q_$>C2:PELBWC01PR>8T?EAUE(Z;@>H!YQ52^\,?;6E,U_,!=0K;WJHH
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MHU;3?%L]CIZ:=KEE!<QQXNI'MB1*W'*C/ ZT.;[,%AX.W[R.OKIZZ=3K<"C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)YUV?ZQ4V^^3]*S?$&GW^HRQS6>FO;:BT<:+>BZ \C#$X90?F RW8YS77T4
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M4 %%%% !1110 4444 %%%% !7*^#?^1B\=_]AJ/_ --UG755RO@W_D8O'?\
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MK*"V@!$4*"-,G)P!@5T+$25)T_ZL<[P\7553^KG(^.KB/0M3TS6XX2TP=H9
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MXM_Z%:V_\&:__$4[4O\ DJ?A[_L"ZG_Z/L*ZJ@#D_P"U_%O_ $*UM_X,U_\
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M;_P9K_\ $56^'$UW/J?C:34;5;2Z;6DWPK+Y@7_0+/'S8&<C!_&NUKE?!O\
MR,7CO_L-1_\ INLZ .JHHHH **** "BBB@ HHHH Y74O^2J>'O\ L"ZG_P"C
M["NJKE=2_P"2J>'O^P+J?_H^PKJJ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HIK.JXW,!DX&3C)KF=3\:Z5:37%O%(T]U&,*B+D,_]W/UX_&KA3E-
MVBKD2J1AK)G445RNA^*I-1O[6"XT^:T2=&"O+QND7!*CVP:ZJB<)0=I!"<9J
M\0HHKF=6UR:XU&;1M#7=J*C]Y*X^2!2!\WN>>GK2A!S=D.<U!79TU)GFN!M?
M%=W%H]Q8Y^T^(+>Y^RJH7(E.X_-], _E5;4+;6_#\EEJ-M)/?ZA=(Z7$;C<J
M' ;"@>F#6ZPSO9NW;S_X!@\2K72OW\CT9F"@EB  ,DGM7':MX@N-5G&FZ%!<
M-%,PB>^5<*@S\Q7UX#<U1_LSQ-?K#'>73BTU!=UTH(!MQDG:OID$#\Z[NSMH
MK2UBMX%"Q1*$4#L!2M&EK\3&I2JZ+1%73=(M-/TX6=M'^ZPP)8Y9L]<GWK@K
M9YX/A_>Z0F?MD=ZUA&$_C8N&(_(M7IO:O+;&*YE^)<]M!YALX[MKJ11]U6VG
MYC^)Q^-:8=N7,WTU^XSQ"4>5);Z?>>@>'=.CTK1;6TB0KL3+ G)W'D_J36E0
M**Y)2<G=G7%**L@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *Y7P;_P C%X[_ .PU'_Z;K.NJ
MKE?!O_(Q>._^PU'_ .FZSH ZJBBB@ HHHH **** "BBB@#E=2_Y*IX>_[ NI
M_P#H^PKJJY74O^2J>'O^P+J?_H^PKJJ "BBB@ HHHH **** "BB@G'6@ HK&
M;Q+I"Z@UD;Z(3  ]?EY.,9]>:S;OQQIMNQ'DWDF2RQ.L7RRD<?*>_-:*C4EL
MC-UH+=G5U#=7,-K&9+B5(T'=CC_/2N8EU;7-4CE@TS3&LG P\MTV-N>A7'4X
MYJ6'P;:-<>;J%S=WY/++.^58XP"1[ D?C5>S4?XC_4GVCE\"_0PK_P 7ZJUT
M18VI\N]3;IZLHW'!Y<Y]><#Z4_3O&#Z):M9:ZTL^H13JC8^\$8!L^^"<?E7:
M3:7:RWUE=-'^\LPPAQP%W  \?04UM'L7U,Z@]M&UT4$9<C/ K7VU)KE<?Z_X
M8R]E5O=2.6CT35?$=L+S69UMW,(-HD61Y3'D,P]>@Q[5T>D:!8:;#;B."-IX
MHA$9BHW,,Y)/U/-:U%8SK2DK;+L;0HQB[O5G,>.]'N-3TZ*6R=UN+1C-&J?>
M9L< >G-<UX:UW5-/UVTT;5 P2-V21^I9I/F4L>W4XKTRN=\<6;3>&[\V<.Z[
M^1U*+\Q*L#^8&:UHU5;V4UH_P,JU)I^U@]?S,^]U:ZU_66TK1+E[:WB#?:+M
M4ZD;?E4^O-;OA_18='M6BC9I9&=F:5^7;)SR:3POIS:7H=K;3!//529"O\3$
M\FM:LZDU\$-OS-*<'\<]_P C'GT.!_$%IJB!$DA1U8!?O[NA^HRWYUL8HHK)
MR<K7-%%1V"BBBD4%9%GHD=KX@OM421BUTBJT>.%P!S^E:]%-2:NEU)<5*S?0
M****104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5RO@W_ )&+QW_V&H__ $W6==57*^#?^1B\
M=_\ 8:C_ /3=9T =51110 5S6MZW<6&O+;M+!:V/E1/YTUO(X9F=@R[U^5<
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M1-/"8AGCDJIQT/-;0I*27O(QG5Y6_=9J?\)_X9_Z"8_[\R?_ !-'_"?^&?\
MH)C_ +\R?_$TB^,- :R^T(X<Y51$L679B!P!^-5WU?648W;>'T&G CY.LY7C
MD <?A0J$^JMZZ![>'1W]"S_PG_AG_H)C_OS)_P#$TO\ PGWAG_H)C_OQ)_\
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MC:\L)?-MI-:38^TC.+"S!X//4&NP\B+_ )Y)_P!\BN8\%J%\0^.@H ']M1\
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M*IX>_P"P+J?_ */L*ZJN5U+_ )*IX>_[ NI_^C["NJH **** "BBB@ HHHH
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M /!B]'_"%K_T,'B/_P &+T =917)_P#"%K_T,'B/_P &+T?\(6O_ $,'B/\
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M *&#Q'_X,7H ZRBN3_X0M?\ H8/$?_@Q>C_A"U_Z&#Q'_P"#%Z .LKE?!O\
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MRW2:19)J+![U84$[#H7P-Q_/- %RBBB@ HHJAK%Y<6D,0L;0W5S-)Y<:%MB
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M>@#>HHHH ***CN)1#!)*P9A&I8A%R3@9X'<T ,N[N"SC5[F58U9UC4L>K,<
M#W)J>N.F%YKNH6\=U$VCZG:K]JM)$<3@QM\CAE( W@8]<$C!/-:/AF&YAO-1
M4S7LNGAD6 WI)D,@W>81GG8?EQGN&QQB@#H**** "BBB@ HHK(FUZUCU\:.R
MS?:S#YX 4;2G/(YY.1C'7VQS0!@ZYK4>L1Q06MK>RPJ_VDQE=@O[=?E?RR#S
M@LK8.-V!C(-1Z;!;:S!J6C6-VUSI$D*O')(I9K1R3F/+<Y& R@\J?; K4U&Q
MU+4TTFXL@FFR1LXD#X9XHV4CY0.-V-O'0'UQST4,8BB1 6;: NYCDG'<GN:
M(M/LXK"SBMK<,(XQP68LQ).223R22223U)JQ110 445DWVN6MGK5EI<PE^TW
M@)B( VG&<\Y[8_'/&>< &-XAUH:C#+IUA!=,[2[4<C9'=&)MTL"OG(8JKCD
M'!Y.#532#:WES<Z7I<C2Z9=VLC2VMS&6^PR@@;2K= VX_(?[I(X)K7U.WU#5
M+*SET^*.RGAO/-C-P,D)M=2Y4=_F)"Y^I'(K=LK?[-:Q1&229D4*9)#EG/J?
M>@"OHNF0Z1IT5I;M(X0?-)*Q9Y&[LQ/4U>HHH ***RM6URUTO4+"SN1+YM\^
MR$J!M)!4'))X^]G]!S@$ RO$6M"YBNM+L%N5N)";>.YQMA,P&[RMX.02 1N
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MV$@#J3D]* ,_1]+GUI[/5M2N7(\H1/"B;%N#%*_ERGOM(._;TY&>E=?0.**
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M"*+?L&%&69FYP!D=B<D<5SK:U<R:[&][87Z?9(RLUI;L9#'(Q^63"X\R-@&
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C "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00006.jpg
<TEXT>
begin 644 image00006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %S B@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z@O[L6<'F
MF*>;G 2&,NQ_ ?S/%0V.K6EYI/\ :,<A6U"NS-(I4IM)#!@>F""#]*378IIM
M/:."W>XW, R1W36[X]5=<'.<<9'&>>QYNSTV]3P\_AF6)5^U6ET#*KY%LCDB
M-2<#>V&.3U.TGGK0!JQ^*M/:*5G6ZB9%C=8I;=E>42-M0HN,G)X]1WQ3QXEL
MC;"14NC,9S;?9A"?.\P+N*[?]WYL],<YK#O-%UC4+N#4IK>W@N;)(%CMQ-N$
MQ20._P V. 0,+[]<5*NCZI'J']LBWB:Z:]:X>S\[&(S L( ;&-WR!O3DC- '
M4Z9?P:E8QW=JS&)\CYE*D$$@@@\@@@@CVJU65X9L)M.TLQW6S[1+/-<R!#E5
M:21GV@]\;L9]JYGXE:?<1VD&H6FLZM9R2:AI]H8[>XVQ[);N&)_EQU*NW/K0
M!W=%<I_PAG_4Q^)/_ [_ .QH_P"$,_ZF/Q)_X'?_ &- '5T5RG_"&?\ 4Q^)
M/_ [_P"QH_X0S_J8_$G_ ('?_8T =717*?\ "&?]3'XD_P# [_[&C_A#/^IC
M\2?^!W_V- '5T5RG_"&?]3'XD_\  [_[&C_A#/\ J8_$G_@=_P#8T =717*?
M\(9_U,?B3_P._P#L:/\ A#/^IC\2?^!W_P!C0!U=%<I_PAG_ %,?B3_P._\
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M]3'XD_\  [_[&C_A#/\ J8_$G_@=_P#8T =717*?\(9_U,?B3_P._P#L:/\
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M3'XD_P# [_[&C_A#/^IC\2?^!W_V- '5T5RG_"&?]3'XD_\  [_[&C_A#/\
MJ8_$G_@=_P#8T =717*?\(9_U,?B3_P._P#L:/\ A#/^IC\2?^!W_P!C0!U=
M%<I_PAG_ %,?B3_P._\ L:/^$,_ZF/Q)_P"!W_V- '5T5RG_  AG_4Q^)/\
MP._^QJ#PM#<:=XYUW2GU*_OK2+3K&ZC%Y+YC(\DMVKX.!P1$G'M0!V5%%% !
M1110 4444 %<K\2_^1=L_P#L-:3_ .G&WKJJY7XE_P#(NV?_ &&M)_\ 3C;T
M =51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7*Z;_ ,E3\0_]@73/
M_1]_755RNF_\E3\0_P#8%TS_ -'W] '54444 %%%% !1110 5ROQ+_Y%VS_[
M#6D_^G&WKJJY7XE_\B[9_P#8:TG_ -.-O0!U5%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWD8!Y%'/'N'U>M_(^VSW['H=%>>1>--8ETV74(HO"3V,3!)+A==8HC'L6\C
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MFDZ>MK(P9X1;($8CH2N,$UI44<L>P>WJ?S/[S-30-'2SDM$TG3UM9&#/"+9
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M1534_M'V1OLEQ#;..3+*F]5'<XR/YUD:?KDX\$RZU?QJTD,$TY" JLJINVL
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MQ/"__043_OAO\* .LHKD_P#A8GA?_H*)_P!\-_A1_P +$\+_ /043_OAO\*
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ME%^(7AAB0NJ(< G[C=OPIO\ PL3PO_T%$_[X;_"@#K:*Y/\ X6)X7_Z"B?\
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M!&T;6K;R3CH.XYZT6_CJQGT"ZU9;+4Q#;R"-HVM6WDG'0=QSUH]K#N'U*O\
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M'8@@C\*P/B5_R+MG_P!AG2?_ $XV] '58HQ110 8HQ110 8HQ110 8HQ110
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M9]QM'XFH[65_%']BV$PC>*V3[1>JV?F*DH%^O4UW5E:065K';VL8CAC&%0=
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MQ'0D  U=KGJ/FFV=%-<L$@HHHJ"PHHHH **** "BBB@ HHHH **** "BBB@
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M]_):ZVB@#DO.\;_\^N@?]_):/.\;_P#/KH'_ '\EKK:* .2\[QO_ ,^N@?\
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MW\EH\[QO_P ^N@?]_):ZVB@#DO.\;_\ /KH'_?R6CSO&_P#SZZ!_W\EKK:*
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M#E/^$_T#_GIJ'_@LN?\ XW1_PG^@?\]-0_\ !9<__&ZZNB@#E/\ A/\ 0/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+4;32[<3ZA<1V\)=4WR' W$X%6P0>E<??RZAJMI>Z;J5C:I>QQQ7L")+NCD
M?.QB0,'*[3V(:K_A'2+[2()H[R[6:%]K0P@L1;#G,:DGE1Q@\']  #H:***
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MW>5 @12QR3CN3ZGK0 [3[.*PM$MX-_EKDYD=G8DG))9B2223UJQ110 4444
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M5R<XXX YR )I.F127(U:XLVM+^4LS1"4XZD*S*#M+[, GGN,XK;HHH ****
M*FK7\>F:=/>3!F2)<[5ZL>@ ]R2!^-<IX@O]8DA@LK[34B-Q*K1BVNBRSA?F
M:!F*KM8J#C^%L$$BNNU"S@U"QGM+M-\$R%'7.,@^_:L:TT.^^T6O]J:I]MM;
M.3S(%, 21F (4R/GYB 3T"\\G- !9V$6KW27]YILUFUNRK;[Y"DCH,']X%;!
M4-R <],]ZZ&BB@ HHHH ;*ZQ1O)(=J*"S'T KC=5UW59M#>X%FMG97T6VWNU
MG+20%QB-Y%"_*"2.5)*Y_$=HP#*00"#P0:Y=?#%PMO\ V:-2SH.X$6K0YE5
M<^4)-WW.V-N<<9H ;:V$>LQ0VU[HUQ86]HGR,\VV19#P51T;)7&<G(SD>]=2
MBA%"J, # %+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
:%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 16, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000947263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TORONTO DOMINION BANK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 16, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$508,000.00</span>. The prospectus is a final prospectus for the related offering.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 508,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-25-038548-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-038548-xbrl.zip
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64$L%!@     !  $ /@   (P(      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000947263</identifier>
        </entity>
        <period>
            <startDate>2025-10-16</startDate>
            <endDate>2025-10-16</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-32">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-33">TORONTO DOMINION BANK</dei:EntityRegistrantName>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-26">&lt;div style="text-align: center; font-family: Arial; font-size: 12pt;"&gt;The maximum aggregate offering price of the securities to which the prospectus relates is &lt;span style="text-decoration-thickness: initial; float: none; display: inline !important;"&gt;$508,000.00&lt;/span&gt;. The prospectus is a final prospectus for the related offering.&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="c0" decimals="2" id="ixv-34" unitRef="usd">508000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-35">true</ffd:FnlPrspctsFlg>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-38">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-39">0000947263</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-40">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OfferingTableNa contextRef="c0" id="ixv-41">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-42">N/A</ffd:OffsetTableNa>
    <ffd:RegnFileNb contextRef="c0" id="ixv-43">333-283969</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-44">424B2</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
